Your new experience awaits. Try the new design now and help us make it even better

REVIEW article

Front. Mol. Biosci., 04 September 2025

Sec. Cellular Biochemistry

Volume 12 - 2025 | https://doi.org/10.3389/fmolb.2025.1638042

Oxidative stress: from molecular studies to clinical intervention strategies

  • 1Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China
  • 2Beijing University of Chinese Medicine, Beijing, China
  • 3College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, Jilin, China

The imbalance between the generation of free radicals and the body’s capacity to counteract their damaging effects on proteins, lipids, and nucleic acids is known as oxidative stress. Since it is essential for controlling many biological functions, this imbalance is intimately associated with the development and course of many diseases. In this study, we first outlined the submechanisms of oxidative stress, concentrating on the antioxidant system and reactive oxygen species. We also discussed common detection methods that can be beneficial for both clinical and scientific purposes. We examined prevalent diseases such as cardiovascular issues, diabetes, cancer, and neurodegenerative disorders to highlight the significant impact of oxidative stress. Additionally, we provided a list of common antioxidants to assist in clinical treatment and further exploration of underlying mechanisms. Our findings indicate that the molecular mechanisms of oxidative stress have been more thoroughly investigated, underscoring its scientific and clinical importance in understanding disease development and potential interventions. We propose that ongoing, in-depth research centered on oxidative stress could offer new insights for clinical interventions and mechanism exploration.

1 Introduction

An imbalance between the body’s oxidative and antioxidant mechanisms is a hallmark of oxidative stress (OS). Reactive oxygen species (ROS) is a broad term that encompasses oxygen-containing free radicals and peroxides that readily generate free radicals during oxygen metabolism. This includes superoxide anions (O2-), hydroxyl radicals (·OH), and hydrogen peroxide (H2O2). In humans, a primary source of ROS is the metabolic byproduct end of the respiratory chain located in the inner mitochondrial membrane. When mitochondrial function is impaired, enzyme complex IV in the inner mitochondrial membrane fails to produce water as it should, resulting in the production of O2-, which subsequently convert into ·OH and H2O2. This disruption can negatively affect the physiological functions of proteins, lipids, and even DNA (Viebahn-Haensler and León Fernández, 2024). Conversely, the human body has natural antioxidant systems, which include an enzymatic antioxidant system comprising superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px), among others (Napolitano et al., 2021). Additionally, there is a non-enzymatic antioxidant system that includes compounds such as ergothioneine, vitamin C, vitamin E, glutathione, melatonin (MT), alpha-lipoic acid (ALA), carotenoids, and trace elements like copper, zinc, and selenium (Se). Consequently, oxidative stress typically arises from a general imbalance between oxidative and antioxidant systems.

2 Molecular mechanism of oxidative stress

2.1 Reactive oxygen species

ROS encompass O2- , ·OH , and H2O2. The primary source of ROS is the electron transport chain (ETC) located in the mitochondria (Mapuskar et al., 2024). In the respiratory chain, electron transmission is facilitated by four complexes and electron carriers on the inner mitochondrial membrane. This results in the production of H2O at complex IV and the creation of a gradient in proton concentration across the membrane, which promotes the synthesis of ATP. O2 may prematurely take up electrons from the ETC during this process, producing a small amount of O2-. (approximately 0.1%) (Mapuskar et al., 2017). In certain situations, such as aging, the ETC’s functionality may decline, leading to an excessive diversion of electrons from the ETC pathway, which then react with O2 to generate significant amounts of O2-, the precursors to most ROS (Nilsson and Tarnopolsky, 2019; Sohal, 1993). The disproportionation of O2- (either naturally or through the action of SOD) results in the formation of H2O2, which can be fully reduced to H2O or partially to ·OH, known to be among the most potent oxidants in nature (Turrens, 2003). Additionally, O2- then can quickly reacts with nitric oxide (NO) to form peroxynitrite (ONOO−). Intense physical activity can also lead to an excessive generation of ROS within the mitochondria (Powers et al., 2020). ·OH can inflict significant damage to lipids, proteins, and DNA, thereby disrupting the balance of various bodily systems due to oxidative stress. While ROS are frequently associated with “damage” and “destruction”, they also play crucial physiological roles in the human body. For instance, phagocytes utilize ROS generated by NADPH oxidase (NOX) to eliminate pathogens (Lambeth, 2004). Consequently, conditions that promote phagocyte proliferation, such as the inflammatory response, lead to the production of substantial amounts of ROS via NOX. Furthermore, non-phagocytic cells have been found to express NADPH oxidase (NOX4) specifically, which causes a considerable amount of ROS to be produced in a particular organ (Shiose et al., 2001; Geiszt et al., 2000). In summary, O2-, ·OH,and H2O2 are produced in significant amounts during aging, inflammation, and other external stimuli, causing harm to normal cells and contributing to the oxidative stress imbalance.

2.2 Antioxidant system

The human body’s antioxidant system consists of both enzyme-based and non-enzyme-based components. The enzyme antioxidant system includes SOD, CAT, and GSH-Px, among others. The non-enzyme antioxidant system comprises substances such as ergothioneine, vitamins C and E, glutathione, MT, ALA, carotenoids, and trace elements like copper, zinc, and Se.

2.2.1 Enzymatic antioxidants

SOD plays a crucial role by converting O2- into H2O2, marking the initial step in the antioxidant process (Powers et al., 2020). While H2O2 is still quite toxic, it prevents the reaction between O2- and nitric oxide (NO) that would produce peroxynitrite (ONOO−). There are three types of SOD in the human body: manganese-dependent SOD (MnSOD) found in mitochondria, and copper-zinc-dependent SOD (CuSOD and ZnSOD) located in the cytoplasm (Hearn et al., 1999). Once H2O2 is formed, additional enzymes are needed to prevent the generation of more harmful ·OH. The primary enzymes responsible for this transformation in the human body are CAT and GSH-Px. CAT converts H2O2 into H2O and O2 using two H2O2 molecules without requiring extra electrons. In contrast, GSH-Px reduces H2O2 to H2O by utilizing additional electrons provided by reduced glutathione (GSH). Additionally, peroxiredoxin (Prx) is key component of the antioxidant system. Prx is a type of peroxidase, primarily functions to eliminate H2O2 from the body.

2.2.2 Non-enzymatic antioxidants

There are numerous types of non-enzymatic antioxidants. Some non-enzymatic antioxidants exert their effects by participating in the catalytic reactions of various enzymes. For instance, trace elements such as copper and zinc are important components of SOD. Glutathione, on the other hand, reduces H2O2 to H2O by providing additional electrons. Some other non-enzymatic antioxidants possess their own reducing properties. Ergothioneine is a natural amino acid derived from plants and can accumulate in animals, which can effectively remove ·OH groups and prevent the formation of ·OH from H2O2. The fat-soluble vitamin E and the water-soluble vitamin C complement each other and jointly maintain the balance within cells. ALA is an organic compound that is both lipid-soluble and water-soluble which has significant electron affinity and the ability to react with free radicals, thus possessing strong antioxidant properties. MT,one of the hormones secreted by the pineal gland in the brain, has strong neuroendocrine immune regulatory activity and the ability to scavenge free radicals and act as an antioxidant. Carotenoids are the main source of vitamin A in the body and also possess antioxidant properties. Trx is one of the important redox regulatory molecules within cells. It helps maintain protein stability, thus preventing protein oxidation (Murphy, 2012).

3 Common detection methods

3.1 The principle of the assays

3.1.1 Free radical scavenging kinetics

The oxygen-radical antioxidant capacity (ORAC) assay determines antioxidant capacity by monitoring the kinetics of oxidative fluorescence decay. Peroxyl radicals (ROO•), generated through controlled thermal decomposition of 2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH) at physiological temperature (37 °C), oxidize a fluorescent probe (e.g., fluorescein). This oxidation induces progressive diminution of fluorescence intensity. Antioxidants interfere with this decay process by scavenging radicals, and their radical-scavenging capacity is quantified by calculating the net area under the time-dependent fluorescence decay curve (AUC) relative to the radical-exposed control (Miller et al., 1993; Ou et al., 2001). The total radical-trapping antioxidant parameter (TRAP) assay quantifies the capacity of antioxidants to delay fluorescence decay in a probe (such as R-phycoerythrin or dichlorofluorescein) under controlled peroxidative conditions initiated by AAPH-generated ROO•. Antioxidant capacity is determined by the length of the lag phase relative to a standard reference compound, typically Trolox (Prior et al., 2005; Ghiselli et al., 1995; Valkonen and Kuusi, 1997). The total oxidant scavenging capacity (TOSC) assay quantifies antioxidant capacity by measuring inhibition of α-keto-γ-methylthiobutyric acid (KMBA) oxidation to ethylene. ROO•generated through thermal decomposition of 2,2'-azobis (2-amidinopropane) AAPH, initiate this oxidation. Ethylene generation kinetics are monitored via headspace gas chromatography (HS-GC). Antioxidant activity is quantified by the reduction in area under the ethylene concentration-time curve relative to the radical-only control (Amorati and Valgimigli, 2015). The β-carotene bleaching assay quantifies antioxidant capacity by measuring inhibition of oxidative discoloration in a lipid peroxidation system. ROS generated during oxidation of unsaturated fatty acids, degrade β-carotene. This degradation manifests as decreased absorbance at 470 nm. Antioxidants retard the discoloration rate by suppressing lipid peroxidation chain reactions (Gulcin, 2020).

3.1.2 Chemiluminescence quenching

Chemiluminescent assays quantify antioxidant activity by measuring the attenuation of chemiluminescence generated through reactions between ROS and specific probes such as luminol or lucigenin. Antioxidants reduce signal intensity either by competing with these probes for oxidants (notably H2O2) or by quenching generated radicals including O2- and hydroxyl radical (OH·) (Shahidi and Zhong, 2015; Shivakumar and yogendra kumar, 2018). Photochemiluminescence assay quantifies antioxidant activity by monitoring O2- radical scavenging capacity. A mercury lamp (λ = 351 nm) excites a photosensitizer to generate O2- radicals. Antioxidant activity is determined by the sample’s ability to scavenge these radicals, with results expressed as Trolox equivalents based on the chemiluminescent intensity of residual radicals (Neculai et al., 2023).

3.1.3 Reducing power of single electron transfer

The Folin-Ciocalteu assay quantifies total phenolic content (TPC) through a single electron transfer (SET) mechanism in alkaline medium. Phenolic compounds reduce the phosphomolybdate complexes present in the Folin-Ciocalteu reagent, forming a blue chromophore with maximum absorbance at 765 nm. This absorbance is directly proportional to phenolic concentration (Singleton et al., 1999; Shahidi and Zhong, 2015). The cupric reducing antioxidant capacity (CUPRAC) assay quantifies antioxidant activity through the reduction of Cu2+-neocuproine to Cu+-neocuproine under near-neutral conditions (pH 7.0). This reduction generates an intense yellow chromophore exhibiting maximum absorbance at 450 nm (Apak et al., 2022; Gulcin, 2008; Tutem et al., 1991). The ferric reducing antioxidant power (FRAP) assay measures the reduction of the ferric 2,4,6-tripyridyl-s-triazine complex [Fe3+-(TPTZ)2]3+ to the blue ferrous complex [Fe2+-(TPTZ)2]2+ by antioxidants in acidic medium (pH 3.6), monitored by absorbance increase at 593 nm (Benzie and Strain, 1999).

3.1.4 Stabilization of free radical scavenging

The 1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay quantifies antioxidant capacity by measuring the reduction of the stable DPPH• radical through hydrogen atom transfer (HAT) or electron transfer (ET) mechanisms. This reaction induces decolorization from purple to yellow, characterized by a decrease in absorbance at 517 nm, which is monitored spectrophotometrically (Brand-Williams et al., 1995). The trolox-equivalent antioxidant capacity (TEAC) assay quantifies antioxidant capacity by measuring the decolorization of the pre-formed blue-green ABTS+• radical cation (λmax = 734 nm) following radical scavenging; the reduction in absorbance is measured spectrophotometrically and expressed as Trolox equivalents (Prior et al., 2005).

3.2 Advantages and limitations of the assays

3.2.1 ORAC

The ORAC assay facilitates high-throughput screening through microplate-based parallel analysis. This method utilizes biologically relevant ROO• generated from 2,2'-azobis (2-amidinopropane) AAPH and employs AUC quantification to provide a comprehensive kinetic assessment of antioxidant activity. The assay accommodates both hydrophilic and lipophilic antioxidants; the latter requires solubility enhancers such as randomly methylated β-cyclodextrin (RMCD). However, several limitations exist. Strict control of buffer conditions (pH 7.4) is essential due to the pH sensitivity of the fluorescein probe. Furthermore, AUC integration inherently combines kinetic and stoichiometric data, potentially complicating interpretation. The relatively low radical reactivity of fluorescein may lead to underestimation of potent antioxidants with rapid reaction kinetics. Finally, precise temperature maintenance at 37 °C is critical throughout the assay procedure (Ou et al., 2001; Huang et al., 2002; Shivakumar and Yogendra kumar, 2018).

3.2.2 TRAP

A key advantage of this assay is its sensitivity to all known chain-breaking antioxidants, with established clinical correlations in various disease states (Prior et al., 2005). However, significant limitations include operational complexity, time-consuming procedures requiring specialized expertise, and reliance on lag phase quantification. This reliance fails to capture the activity of antioxidants lacking distinct lag phases and disregards post-lag phase contributions. Furthermore, stability issues associated with oxygen electrodes further compromise reproducibility (Rice-Evans and Miller, 1994; Somogyi et al., 2007).

3.2.3 TOSC

The TOSC assay quantifies antioxidant capacity by measuring the integrated inhibition of ethylene formation—determined via AUC analysis—during KMBA oxidation. This method eliminates interference from colored matrices through headspace gas chromatographic detection (Winston et al., 1998). However, the approach suffers from significant limitations: a time-consuming analytical workflow requiring multiple chromatographic runs per sample, and compromised mechanistic interpretability due to the AUC-based evaluation. This integration method inherently fails to distinguish between kinetic reactivity and stoichiometric parameters.

3.2.4 β-Carotene bleaching assay

This method enables rapid screening of lipid-soluble antioxidants in emulsion systems. However, it exhibits significant limitations including quantification inaccuracies, limited reproducibility, and complex reagent preparation. Furthermore, measurements are susceptible to interference from pH fluctuations, temperature variations, and solvent effects, compromising reliability for absolute quantification (Alam et al., 2013; Apak et al., 2022).

3.2.5 Chemiluminescence assay

This assay offers exceptional sensitivity for ROS detection through chemiluminescent probes such as luminol and lucigenin, enabling quantification of antioxidant activity via light emission quenching. Its versatility permits application across diverse oxidant-catalyst systems. Key limitations, however, include dependence on specialized instrumentation (e.g., luminescence photometers), susceptibility to interference from catalysts or enhancers, and pH-dependent mechanistic variations in the luminol reaction (Shahidi and Zhong, 2015).

3.2.6 Photochemiluminescence assay

The photochemiluminescence assay enables precise quantification of O2- scavenging capacity through controlled photochemical generation and luminescence detection. Utilizing physiologically relevant O2-, this approach mimics oxidative stress conditions with high sensitivity (Chiefa et al., 2024). However, limitations include a restricted quantification range where undiluted samples (e.g., T96/F96 concentrations) inhibit calibration curve fitting, necessitating serial dilution (1:10–1:200) for accurate measurement. Additionally, reliance on specialized instrumentation (e.g., Photochem systems, Analytik Jena) and proprietary reagent kits constrains methodological accessibility.

3.2.7 Folin-ciocalteu

This assay demonstrates operational simplicity, high reproducibility, and sensitivity, making it broadly applicable for estimating the reducing capacity of plant and food extracts. Its commercial availability further enhances practical utility (Singleton and Rossi, 1965; Prior et al., 2005). Notable limitations include non-specificity: numerous non-phenolic reducing agents (e.g., ascorbic acid, proteins, reducing sugars, and certain inorganic ions) react, leading to overestimation of TPC. Additionally, it is unsuitable for lipophilic antioxidants and exhibits significant pH- and temperature-dependence, requiring strict experimental control (Singleton et al., 1999; Prior et al., 2005; Shahidi and Zhong, 2015). The principles, advantages, and limitations of common detection methods are summarized in Table 1.

Table 1
www.frontiersin.org

Table 1. Common detection methods and their principles, advantages, and limitations.

3.2.8 CUPRAC

The CUPRAC assay possesses key advantages, including reagent stability, linearity, and applicability to both hydrophilic and lipophilic antioxidants. Notably, it effectively detects thiol-based antioxidants such as glutathione (Gulcin et al., 2007; Apak et al., 2022; Karaman et al., 2009). However, the method exhibits marked solvent-dependent variations in measured antioxidant capacity, particularly for lipophilic compounds (e.g., BHT and naringenin). Furthermore, suboptimal reaction kinetics under standard conditions have been documented for certain antioxidants (Celik et al., 2010).

3.2.9 FRAP

FRAP assay offers advantages including simplicity, cost-effectiveness, robustness, and applicability to diverse matrices such as biological fluids, foods, and plant extracts (Benzie and Strain, 1999; Prior et al., 2005). However, the assay is constrained by several limitations. Its exclusive reliance on an ET mechanism precludes the assessment of HAT-based chain-breaking antioxidant activity or specific radical scavenging capacity. Furthermore, FRAP cannot accurately quantify thiol-containing antioxidants (e.g., glutathione) or carotenoids due to their poor interaction with ferric ions. Slow-reacting polyphenols, such as caffeic acid and quercetin, require extended reaction times for precise measurement, potentially leading to underestimation under standard protocols. Additional constraints include the potential for compounds with redox potentials higher than the Fe3+/Fe2+ couple to overestimate values, and interference from sample chromophores absorbing at 593 nm (e.g., biliverdin), causing overestimation. Moreover, the acidic assay conditions (pH 3.6) can precipitate proteins (e.g., milk casein) and generate pro-oxidant Fe2+ ions, which may propagate radical chain reactions (Benzie and Strain, 1999; Pulido et al., 2000; Pulido et al., 2003; Ou et al., 2002a; Ou et al., 2002b; Prior et al., 2005; Somogyi et al., 2007).

3.2.10 DPPH

The DPPH assay offers several advantages, including simplicity, speed, cost-effectiveness, ease of use (owing to the commercial availability of the stable radical), and broad applicability to both pure compounds and extracts (Gulcin et al., 2007; Shahidi and Zhong, 2015). However, limitations include potential spectral interference from sample chromophores, such as anthocyanins, and the poor aqueous solubility of the DPPH radical. Additionally, the reaction kinetics are often inconsistent and prolonged (Brand-Williams et al., 1995; Bondet et al., 1997; Yamauchi et al., 2024).

3.2.11 TEAC

The TEAC assay provides advantages of simplicity and convenience for high-throughput antioxidant screening through its utilization of the relatively stable ABTS+• radical cation. However, this method relies on single-point measurements (typically recorded at a fixed time, e.g., 5 min), which fail to differentiate between reaction kinetics (rate constants) and stoichiometry (number of radicals trapped per molecule). Consequently, the results become dependent on the arbitrarily selected measurement time point (Re et al., 1999).

3.3 Related applications

3.3.1 ORAC

In a 12-month clinical trial, Donato Di Pierro et al. investigated oxidative stress’s consequences using the ORAC assay and found that coenzyme Q10 may significantly reduce oxidative stress-related damage in RTT erythrocytes (Di Pierro et al., 2020). In a 48-h randomized controlled trial, Angela R Hillman et al. reported no impact of acute Montmorency sour cherry intake on oxidative capacity after testing 48 participants with the ORAC method (Hillman and Uhranowsky, 2021). Ariko Umezawa et al. discovered a positive correlation between cholesterol efflux capacity and ORAC in a randomized, parallel-controlled clinical trial that examined cholesterol efflux after a 6-month Japanese diet (Umezawa et al., 2022). Carolina Fredes et al. investigated two of Chile’s southernmost berries, murtha and calamansi, and identified them as fruits with high ORAC values and natural antioxidant properties (Fredes et al., 2020). Additionally, Samia Elbahnaswy et al. suggested that astaxanthin could be a beneficial agent for preventing various oxidative stress-related diseases in aquatic animals, making it a promising candidate (Elbahnaswy and Elshopakey, 2024).

3.3.2 TRAP

Marge Kartau et al. conducted a study analyzing TRAP and UA levels in 112 multiple sclerosis patients, discovering a positive correlation between UA and TRAP levels, with men exhibiting higher TRAP values than women (Kartau et al., 2024). Fatemeh Toorang et al. found in a large clinical study that diets rich in antioxidants, such as FRAP or TRAP, lowered the risk of developing head and neck cancer (HNC) and its subtypes (Toorang et al., 2023). G. Godoy et al. concluded from an experiment on plasma non-enzymatic antioxidant capacity in rats subjected to intense swimming that the TRAP assay is the most effective method for evaluating plasma non-antioxidant capacity following vigorous exercise (Kartau et al., 2024). The most sensitive assay for plasma non-antioxidant capacity post-exercise was identified (Godoy et al., 2022). Walter Sepúlveda-Loyola et al. utilized the TRAP assay in a clinical study to assess antioxidant capacity, finding a connection between COPD patients’ sarcopenia and oxidative stress (Sepúlveda-Loyola et al., 2021).

3.3.3 TOSC

Mohamed Dellali and colleagues found a substantial rise in total oxygen radical scavenging capacity (TOSC) after 7 days of exposure to two concentrations of benzo [a]pyrene (B [a]P) (100 and 300 μg/L) in the digestive glands, with the lowest concentration showing the most significant increase (Dellali et al., 2021). The non-alcoholic steatohepatitis (NASH) model exhibited a significantly lower antioxidant capacity compared to the NO-NASH model, which is characterized by a dietary pattern rich in polyphenols, vitamins, and fiber, similar to the Mediterranean diet (Vitale et al., 2022).

3.3.4 β-Carotene bleaching assays

Fatimata Nea et al. assessed the antioxidant capacity of Lantana rhodesiensis Moldenke extracts using DPPH, FRAP, and β-carotene bleaching tests, revealing that leaf extracts had higher antioxidant activity than stem and root extracts, likely due to a higher presence of polyphenols, including flavonoids. Positive linear correlations were found between phenolic content (total polyphenols, including flavonoids and tannins; and total flavonoids) and the antioxidant activity of all extracts (Nea et al., 2021). The antioxidant potential of hesperidin-related substances was assessed by Hyo-Jun Lee et al. using both DPPH and β-carotene bleaching methods, finding that all tested compounds exhibited antioxidant activity in a concentration-dependent manner, but to differing degrees (Lee et al., 2024). Nyayiru Kannaian reported significant antioxidant activity in coconut cotyledons as measured by DPPH, FRAP, NO, and β-carotene bleaching assays (Nyayiru Kannaian et al., 2020). Maria García-Nicolás et al. established a correlation between citrinin content and antioxidant activity as measured by the β-carotene bleaching assay (García-Nicolás et al., 2023). According to a study by Zhuang Y et al.acylated pectin showed enhanced antioxidant activity in both the DPPH and β-carotene bleaching assays, along with notable antimicrobial properties (Zhuang et al., 2022).

3.3.5 Chemiluminescent assay

Na Wu et al. developed a novel chemiluminescence platform utilizing semiconducting polymer nanoparticles-manganese (SPN-MnVII) for detecting total antioxidant capacity in the urinary samples of mice with diabetes (Naderi et al., 2023).

3.3.6 Photochemiluminescence assay

Mihaela Multescu and colleagues utilized the photochemiluminescence assay (PCL) along with methods such as DPPH, ABTS, Ferric Reducing Antioxidant Power (FRAP), and Copper Ion Reducing Antioxidant Capacity (CUPRAC) to assess the total antioxidant capacity (TACO) of vegetable oils sourced from the vegetable oil industry. They found a strong positive correlation between the fat-soluble antioxidant capacity (ACL) of 14 different by-products (including flour, crude flour, and hulled) measured by PCL and the other antioxidant activity methods (Multescu et al., 2022). Neculai AM and others evaluated the antioxidant capacity of oils from the vegetable oil industry using the DPPH radical scavenging assay and photochemiluminescence, discovering a strong link between antioxidant activity and the presence of phenolic compounds in the maceration solution (Neculai et al., 2023). Rajagukguk YV and colleagues noted a robust relationship between antioxidant activity and overall phenolic content (measured by ORAC, DPPH, ABTS, and PCL), with antioxidant activity declining as total phenolic content decreased over 2 months of storage (Rajagukguk et al., 2022).

3.3.7 Folin-ciocalteu

Haldar et al. found that consuming (poly)phenol-rich curry, evaluated through the urinary Folin-Ciocalteu assay, improved glucose regulation in 20 healthy men (Haldar et al., 2019). In older populations from the PREDIMED and InCHIANTI studies, individuals with higher urinary (poly) phenol excretion exhibited better cardiovascular health indicators, including glucose and triglyceride levels, blood pressure, and body weight (Guo et al., 2016). Laveriano et al. reported that urinary polyphenols correlated with improved cardiovascular profiles in a Spanish adolescent group, with boys showing a stronger correlation than girls (Laveriano-Santos et al., 2020). Arancibia et al. demonstrated that urinary total (poly) phenol excretion, measured by the Folin-Ciocalteu assay, could serve as a reliable biomarker for an anti-inflammatory diet, particularly in females, supporting the inverse relationship between total polyphenol intake and inflammation (Arancibia-Riveros et al., 2023). Motto AE et al. conducted in vivo studies on the anti-hyperlipidemic effects of total extracts and supernatants from Anogeissus leiocarpus using a fructose overload assay in ICR mice, assessing total polyphenols and flavonoids through colorimetric assays with Folin-Ciocalteu reagent and aluminum chloride. They found that the extracts exhibited strong antihyperlipidemic and antioxidant properties, rich in polyphenols, which could be beneficial for treating diabetes-related macrovascular complications (Motto et al., 2021). Mamri S et al. employed the Folin-Ciocalteu reagent to evaluate total phenolic content in androgynous extracts, while the aluminum chloride method was used for total flavonoid content. Phytochemicals were quantified and identified using HPLC-DAD, and in vitro α-amylase inhibition tests indicated that C. sativus stamens effectively lower postprandial blood glucose levels (Mamri et al., 2024).

3.3.8 CUPRAC

Milena Polumackanycz and colleagues conducted a thorough investigation into the antioxidant capacity of common and lemon verbena leaves using DPPH, ABTS+•, FRAP, and CUPRAC methods. They found that lemon verbena exhibited greater antioxidant activity than common verbena, which correlated positively with its phenolic content (Polumackanycz et al., 2022b). Leyla Polat Kose and her team also explored the antioxidant capacity of various phytolignans and mammalian lignans through ABTS+•, DPPH, CUPRAC, and FRAP, discovering that phytolignans, as secondary metabolites in plants, demonstrated relatively high antioxidant activity, while enterodiols and enterolactones showed weaker activity compared to phytolignans and standard antioxidants (Polat Kose and Gulcin, 2021). Mine Aydın Kurç et al. assessed the hexane extract of Cirsium vulgare using TEAC, FRAP, CUPRAC, a β-carotene bleaching assay, and O2- scavenging activity measurements, revealing that the methanolic extract had the highest total flavonoid content and antioxidant capacity (Aydın Kurç et al., 2023). Milena Polumackanycz et al. compared the antioxidant capacity of aqueous and hydro-methanolic extracts using DPPH, ABTS+•, FRAP, and CUPRAC, finding that the hydro-methanolic extract of R. rosea was richer in phenolic compounds and exhibited superior antioxidant and neurobiological activities compared to the aqueous extract (Polumackanycz et al., 2022a). Bailey R. Meyer and colleagues evaluated the antioxidant capacity of 15 commercially available green teas using CURPAC and ORAC, discovering that matcha, gunpowder, and bagged green teas had higher total phenolic content and stronger CUPRAC and ORAC antioxidant capacities compared to other teas (Meyer et al., 2023). Yara Salem et al. utilized DPPH, CURPAC, and FRAP to assess the antioxidant capacity of seeds from Obeidi, Asswad Karech, Marselan, Syrah, and Cabernet Franc, finding that Marselan had the highest total phenolic and proanthocyanidin content, along with the greatest antioxidant activity (Salem et al., 2022).

3.3.9 FRAP

Paiva et al. detailed the preparation and findings of antioxidant studies on peptide fractions derived from protein hydrolysates of Spirulina muricata, with Fr3 showing the highest FRAP activity. The relevant applications of common detection methods are shown in Table 2. Additionally, Fr3 demonstrated significant angiotensin I-converting enzyme (ACE) inhibitory activity (Paiva et al., 2017). Kimatu et al. investigated the antioxidant activity of protein hydrolysates from Agaricus bisporus using DPPH and FRAP assays, finding that all hydrolysates and peptide fractions exhibited a concentration-dependent increase in iron-reducing antioxidant capacity, with trypsin hydrolysates showing the highest FRAP (Kimatu et al., 2017). Antioxidant activity was assessed using DPPH, ABTS, FRAP, and CUPRAC, confirming that exposure to ionizing radiation did not alter the chemical structure or antioxidant properties of the tested flavonoids (Rosiak et al., 2023).

Table 2
www.frontiersin.org

Table 2. Common detection methods and their applications.

3.3.10 DPPH

Baliyan S. et al. evaluated the antioxidant capacity of F. religiosa using DPPH and concluded that it possesses antioxidant properties that could be beneficial in treating diseases linked to free radicals (Baliyan et al., 2022). Iordănescu O. et al. discovered that ripe papaya pulp extracts exhibited the highest antioxidant activity measured by DPPH, being 1.2–1.4 times greater than other ripe papaya extracts (Iordănescu et al., 2021). Addo P.W. et al. investigated the relationship between total antioxidant capacity, cannabinoids, and terpenoids in hops and cannabis, finding that the DPPH assay indicated a significant reduction of 60.5% in antioxidant activity of cannabis after freeze-drying and MAHD compared to pre-freezing samples, although no significant change was observed with the FRAP method (Addo et al., 2023). Bordt E.A. et al. reported that Mdivi-1 displayed antioxidant activity in both ABTS and DPPH assays (Bordt et al., 2022). Jin Y. found that testing the antioxidant capacity of Levilactobacillus brevis strains resulted in a significant increase in DPPH and FRAP, alongside a decrease in ABTS antioxidant capacity (Jin et al., 2023). Keyla Rita et al. conducted a randomized controlled clinical trial with 31 subjects, testing antioxidant capacity before and after using FRAP, DPPH, and ABTS, and found that baobab fruit extracts significantly reduced the incremental glycemic AUC while demonstrating considerable suppression of reactive oxygen species and antioxidant activity (Rita et al., 2022).

3.3.11 TEAC

ChochevskaM and team assessed the antioxidant properties of traditionally prepared homemade fruit vinegar through the ABTS+• method. Their independent assessments of antioxidant capacity, utilizing the TEAC assay—which is intended to align with electrochemical experiment data—revealed that all homemade fruit vinegars exhibited at least ten times greater antioxidant activity compared to commercial fruit vinegars (Chochevska et al., 2021). ElvenyM et al. discovered that the PSO-ELM model, which is straightforward and precise, effectively predicts Trolox equivalent antioxidant capacity values and can serve as a reliable alternative to laboratory data (Elveny et al., 2021). LiangY et al. assessed antioxidant capacity through the Folin-Ciocalteau and Trolox equivalent antioxidant capacity assays, noting that pH had a more significant impact on antioxidant capacity than the addition of cysteine. Their findings suggest that alkaline chlorogenic acid (CGA) quinone amine greening could be a viable anti-greening strategy (Liang and Were, 2020). TanakaM et al. reported that treatments with ARB and IGF-1 enhanced Trolox-equivalent antioxidant capacity and increased levels of antioxidant enzymes (Tanaka et al., 2024).

4 Oxidative stress in various diseases

4.1 Alzheimer’s disease

Alzheimer’s disease (AD) involves a range of complex mechanisms and theories, with oxidative stress and its detrimental effects on neurons being fundamental components in all these processes. Under normal conditions,ROS are essential for signaling pathways and transcription activation, and they are closely linked to the different pathogenic processes of AD. However, when ROS levels rise beyond the capacity of antioxidants, they can damage cellular macromolecules, disrupt normal cell functions, trigger mitochondria to produce pro-apoptotic proteins, and ultimately lead to the apoptosis of central nervous system neurons (Schieber and Chandel, 2014). Oxidative Stress and the Amyloid Cascade Hypothesis: ROS significantly contribute to Aβ (amyloid-β)-induced neuronal apoptosis. Impaired mitochondrial function results in the release of more ROS, which activates pro-apoptotic protein production, culminating in nerve cell apoptosis (Bai et al., 2022). Additionally, extracellular amyloid plaques exacerbate the reaction to oxidative stress. Further advancing the pathological progression of AD. Oxidative Stress and the Tau Hypothesis: ROS attacks tau proteins, leading to interactions with CDK and GSK3β kinases, which causes excessive phosphorylation (Lau et al., 2002; Avila et al., 2010). This process hinders the transport of proteasome peroxidase, resulting in increased oxidative stress. Furthermore, ROS stimulation promotes the formation of disulfide bonds in tau proteins, worsening oxidative stress and encouraging tau accumulation (Saito et al., 2021). Oxidative Stress and the Inflammation Hypothesis: Aging and ROS activation lead to the stimulation of microglia. Once activated, these microglia release ROS, inflammatory cytokines, and chemokines (Thakur et al., 2023), initiating a chronic inflammatory response and enhancing the synthesis of cathepsin B protein (Chaney et al., 2019). These events ultimately result in neuronal dysfunction and apoptosis. Oxidative Stress and the Metal Ion Hypothesis: Different types of ROS interact with various metal valences (Iqbal et al., 2014), intensifying neuronal cell apoptosis and contributing to AD pathogenesis.

4.2 Diabetes

Oxidative stress not only directly harms islet beta cells but also acts as a signaling molecule that activates various stress-sensitive pathways. This regulation influences the expression of related factors, resulting in beta cell apoptosis or necrosis, decreased insulin secretion, and increased insulin resistance, ultimately contributing to the onset or progression of diabetes (Drews et al., 2010). Impact on Islet β Cell Function: Oxidative stress disrupts the structure of mitochondria in islet β cells, leading to apoptosis and The nuclear transcription factor κB (NF-κB) is activated signaling pathway, which triggers inflammatory responses within the cells (Wronka et al., 2022). Furthermore, oxidative stress can impede the nucleoplasmic translocation of pancreaticoduodenal homeobox factor 1 (PDX-1), impair energy metabolism, and reduce insulin production and release (Duni et al., 2019). Induction of Insulin Resistance: Oxidative stress disrupts the activation of phosphatidylinositol 3-kinase (PI3K) by impairing the phosphorylation of insulin receptors (InsR) and insulin receptor substrates (IRS) (Henriksen et al., 2011). Furthermore, it inhibits the translocation of glucose transporter 4 (GLUT4) (Wu et al., 2016) and damages the cytoskeleton, along with other physiological processes related to insulin signaling. This cascade of events ultimately leads to the development of insulin resistance (Moroz et al., 2008).

4.3 Lung cancer

In nearly all cancer types, excessive accumulation of ROS contributes to cancer development by enhancing pro-tumor signaling. There is strong evidence linking elevated ROS levels to cancer progression (Glorieux et al., 2024). Abnormal Cell Signaling Pathways: The epithelial growth factor receptor (EGFR), part of the human epidermal growth factor receptor (HER) family (Yang and Chang, 2018) and transmembrane receptor tyrosine kinase family (Singal et al., 2019), can become abnormal through gene amplification, mutation, or overexpression. This disruption in signaling pathways is a critical factor in tumor formation (Costa et al., 2017; Yewale et al., 2013), particularly in lung cancer, where EGFR plays a vital role (Peifer et al., 2012). DNA Damage: Oxidative stress can inflict DNA damage, hinder DNA repair mechanisms, and promote cell proliferation, facilitating lung cancer development (Stefanou et al., 2022). ROS can directly attack DNA, causing oxidative damage (Taniguchi et al., 2012), including base damage and single-strand breaks, which can cause DNA to mutate and change structurally (Roy, 2014). Additionally, oxidative stress impairs the cell’s ability to repair damaged DNA by affecting related signaling pathways and enzymes, promoting tumor cell proliferation and causing cell cycle arrest, which impacts overall cell proliferation.

4.4 Coronary heart disease

Excessive ROS accumulation has been shown to upset the equilibrium between the oxidation and antioxidant systems, leading to oxidative stress, which is a major factor in the development of coronary heart disease. Promotion of Atherosclerosis: Atherosclerosis is a key factor in coronary heart disease, beginning with endothelial cell injury (Xu et al., 2021). Under oxidative stress, nitric oxide’s biological activity diminishes, affecting blood vessel tension and leading to endothelial dysfunction. Damaged endothelium is more prone to lipid accumulation (Zhang et al., 2018), thrombosis, immune cell invasion (Libby, 2021), inflammatory responses (Ribeiro et al., 2010), and abnormal blood flow, all contributing to atherosclerosis. Excessive ROS disrupt the oxidation-antioxidant balance, activate inflammatory cell signals, and induce endothelial cell dysfunction through mitochondria-mediated apoptosis, promoting vascular smooth muscle cell proliferation, interfering with nitric oxide synthesis, and delaying endothelial repair, thereby accelerating atherosclerosis development (Tullio et al., 2013; Zhang et al., 2015).

Oxidative stress originates from mitochondrial electron leakage at ETC complexes I/III, producing O2- that drive ROS cascades (e.g., H2O2, ·OH). Cellular protection involves enzymatic (SOD, CAT, GSH-Px) and non-enzymatic (GSH, ALA) antioxidants. A sustained ROS imbalance propagates disease-specific pathology. In Alzheimer’s disease, ROS exacerbate Aβ plaque deposition and tau hyperphosphorylation, inducing neuroinflammation. Diabetes pathogenesis features ROS-mediated β-cell apoptosis and impaired GLUT4 translocation, worsening insulin resistance. Lung cancer progression is fueled by ROS-induced EGFR mutations and DNA damage, while coronary heart disease arises from endothelial dysfunction and LDL oxidation. This framework thereby bridges molecular mechanisms to clinical disease, demonstrating oxidative stress as a unifying axis in multifactorial pathologies. Figure 1 shows the relationship between oxidative stress mechanisms and related diseases.

Figure 1
Illustration showing the role of reactive oxygen species (ROS) in various diseases. In Alzheimer's disease, ROS promotes Tau and Aβ aggregation. In diabetes, ROS affects the IRS/PI3K pathway. For lung cancer, ROS leads to DNA fragmentation and EGFR signaling. In coronary heart disease, ROS causes endothelial injury and plaque rupture. Each section highlights the biochemical pathways involved.

Figure 1. Oxidative stress mechanism and related diseases.

5 Exogenous source of antioxidants with therapeutic potential

At present, there are many types of antioxidants in use, including essential oils (EO) (de Sousa et al., 2023) extracted from various plants, ALA which is used clinically to treat diabetic peripheral neuropathy (DPN), phenolic substances, vitamin C and E, MT, etc. Besides their general antioxidant effects, these antioxidants also play significant roles in specific diseases such as neurological disorders, various tumors, cardiovascular diseases, and endocrine disorders.

5.1 Antioxidants for neurological disorders

Neurological diseases such as Alzheimer’s disease and epilepsy, due to their complexity and severity, present numerous challenges in clinical treatment. Due to the crucial role of oxidative stress in it, the use of antioxidants becomes possible. ALA is a commonly used drug in clinical practice for treating DPN. Its ability to protect nerve function and alleviate clinical symptoms has been widely recognized (Fasipe et al., 2023; Oraebosi et al., 2022). In addition,it has also been implicated in other neurological disorders (Khan et al., 2022). A randomized controlled trial indicated that ALA improves psychopathology and lessens oxidative stress in schizophrenic patients who are treatment-resistant schizophrenia (TRS) (Mishra et al., 2022). In epilepsy patients, repeated seizures and prolonged medication can lead to reactive oxygen species production, causing neuronal damage. ALA, as an antioxidant, binds strongly to MnSOD protein, enhancing drug efficacy and inhibiting seizures (Javaid et al., 2022). In animal experiments, ALA also demonstrated a special therapeutic effect on neurological disorders. Animal studies have shown that ALA can mitigate aggressive behavior in mice, suggesting its relevance for psychological disorders (Karim et al., 2023). Studies also have demonstrated that ALA can reduce lipid peroxidation, protein carbonylation, and advanced oxidized protein products induced by the antiepileptic drug valproic acid (VPA) (Turkyilmaz et al., 2020). Additionally, ALA administration in rats post-spinal cord injury has been shown to decrease antioxidant formation (Ercan et al., 2021). Vitamins C and E are natural antioxidants found in the human body. In clinical practice, they are often used as adjunctive medications and work together with other drugs. Research indicates that antioxidants like vitamin E can prevent lipid peroxidation and iron accumulation in neurodegenerative conditions associated with brain iron accumulation (NBIA), partially improving the physiological pathology of affected cells (Suárez-Carrillo et al., 2023). Vitamin C has been shown to alleviate cisplatin-induced neuropathy by increasing levels of heat shock protein-70 and nerve growth factor while reducing inflammation and oxidative stress (Pala et al., 2022).

Apart from the common ALA and vitamins in practice, other antioxidants, although not yet widely used, also show potential in treating neurological diseases. The essential oil from Alpinia zerumbet (EOAZ) has shown effects similar to olanzapine in mitigating schizophrenia-like symptoms induced by repeated ketamine administration, with fewer side effects (de Araújo et al., 2021). Cachrys sicula L. (Apiaceae) EO effectively inhibits key enzymes associated with Alzheimer’s disease, particularly butyrylcholinesterase (BChE) (Tahar et al., 2022). Additionally, phenols have therapeutic potential for AD, stroke, depression, and Parkinson’s disease (Liu et al., 2023). MT and its metabolites regulate various sirtuin pathways related to apoptosis, proliferation, metastasis, autophagy, and inflammation in stroke (Azedi et al., 2022). Its neuroprotective effects have been supported by numerous studies (Sobhani et al., 2023). However, with the exception of a few cases, most of these antioxidants have not been put into clinical use. The complexity of the components (such as EO), the diversity of their effects (such as hormones), and other factors all pose limitations to its treatment of neurological diseases. More clinical trials, rather than just animal experiments, are needed to further confirm its exact efficacy.

5.2 Antioxidants for tumors

Malignant tumors are severe diseases caused by the uncontrolled and abnormal proliferation of cells. How to accurately kill cancer cells and prevent the tumor from continuing to grow has always been a key issue in cancer treatment. And antioxidants have shown certain potential in this regard. Ganoderma EO demonstrated anti-tumor properties, inducing apoptosis in K562 cells and inhibiting cell proliferation by blocking the cell cycle in the S phase (Wang et al., 2023). Prangos pabularia EO (20 μg/mL) exhibited significant cytotoxicity against human lung adenocarcinoma cells (A549) (56.12%) (Banday et al., 2022). The primary component of Inula viscosa EO, (E)-Z-farnesyl acetone, acts as a functional inhibitor of VEGF activity, potentially hindering abnormal angiogenesis in conditions like tumors and diabetic retinopathy (Nadia et al., 2022). Furthermore, turmeric EO exhibits a range of effects, including anti-cancer, anti-inflammatory etc. (Orellana-Paucar, 2024). Polyphenols can exert antioxidant and immunomodulatory effects by targeting NF-κB, thereby inhibiting tumor development (Guan et al., 2022). Phenols derived from extra virgin olive oil (EVOOE) have shown anti-proliferative effects on bladder cancer cells (Spagnuolo et al., 2022). Certain trace elements, such as Se, not only participate in antioxidant processes as oxidoreductase components but also exhibit anti-cancer and immune-regulating effects (Huang et al., 2022; Hariharan and Dharmaraj, 2020; Dogaru et al., 2023). Compared with the highly toxic radiotherapy and chemotherapy, antioxidants are undoubtedly a better treatment option for patients. However, their effectiveness still needs to be explored over a longer period of time.

5.3 Antioxidants for cardiovascular diseases

We know that the elevation of many metabolites can cause damage to the cardiovascular system, such as low-density lipoprotein and glucose. Antioxidants’ protective effect on the cardiovascular system is often achieved by regulating metabolism. In animal studies, administering laurel and myrtle EOs to rats resulted in weight loss and improvements in lipid profiles (cholesterol, triglycerides, LDL-C, and VLDL-C) and atherosclerotic markers by regulating liver lipid metabolism (Odeh et al., 2022). Research has shown that various polyphenols can provide cardiovascular protection by binding to lipoproteins and preventing their oxidation at both lysosomal/inflammatory pH (5.2) and physiological pH (7.4) (Tung et al., 2020). An overview of the above antioxidants, along with their targets and clinical status, is shown in Table 3. Their primary mechanism involves reducing circulating cholesterol, binding to LDL particles, and enhancing systemic antioxidant activity (Ahmadi et al., 2022). Zhang et al. developed a compound by combining the anti-inflammatory and antioxidant polyphenol EGCG with Fe (3+) and atorvastatin, resulting in EGCG-FE-ATV, which demonstrated significant anti-inflammatory, antioxidant, and lipid-lowering effects, along with good biocompatibility and biosafety (Zhang et al., 2023). However, not all antioxidants have a definite effect on the cardiovascular system. The impact of certain phenols on blood lipids may be minimal, as seen with tocotrienol (Zuo et al., 2020). In terms of lipid metabolism, α-tocopherol and ascorbic acid are not effective in inhibiting ferritin oxidation of LDL at lysosomal pH (Ojo and Leake, 2021). This might explain why large-scale clinical trials using these vitamins failed to demonstrate any protective effect against cardiovascular diseases. Regarding glucose metabolism, extracts from Ononis alba Poir L. (Fabaceae) EO showed superior inhibition of α-amylase compared to acarbose (Zaak et al., 2022). In animal studies, MT has been shown to mitigate oxidative stress, apoptosis, and cardiac dysfunction induced by high glucose and STZ by modulating the AMPK/SIRT1 signaling pathway (Wang et al., 2021).

Table 3
www.frontiersin.org

Table 3. Antioxidants and their associated targets, pathways, diseases.

5.4 Antioxidants for other diseases

In other diseases, antioxidants also play a significant role. Numerous studies have highlighted the antioxidant properties of various essential oils (Zhang et al., 2022; Bungau et al., 2023). Additionally, essential oils serve multiple functions. For instance, virgin coconut EO can alleviate asthma symptoms by addressing peribronchial inflammation, epithelial hyperplasia, smooth muscle thickening, and excessive contraction through oxidative stress and its interaction with the nitric oxide pathway (Vasconcelos et al., 2020). Oregano EO is recognized as a natural antimicrobial agent with potential to combat antimicrobial resistance (AMR) globally (Walasek-Janusz et al., 2024). A review identified ALA’s potential renal protective mechanisms in various kidney injury models, including diabetic nephropathy and sepsis-induced kidney injury (Kamt et al., 2023). Furthermore, ALA has therapeutic potential in diabetic retinopathy, dry eye disease, and systemic sclerosis (Ajith, 2020; Xie et al., 2022). Notably, studies in rodents have indicated that ALA can restore sperm function and address infertility (Naderi et al., 2023). Phenols are common antioxidants that play an anti-inflammatory role by regulating lymphocyte and macrophage activity through the modulation of cytokine and nitric oxide release (Pisoschi et al., 2024). Furthermore, phenolic compounds also have therapeutic potential for polycystic ovary syndrome (PCOS) (Sarmadi et al., 2023). MT, a hormone secreted by the pineal gland, possesses strong neuroendocrine immunomodulatory properties and free radical scavenging abilities. Certain amino acids and peptides can counteract intra-lipid peroxidation (Hajieva et al., 2023) and may have implications for treating non-alcoholic fatty liver disease, diabetic complications, and COVID-19 (Kuerban et al., 2020; Wu et al., 2023). However, at present, most of these applications are still at the stage of animal experiments and there is a long way to go before they can be applied in practice.

6 Conclusion

Oxidative stress, defined as an imbalance between the production of reactive oxygen species ROS and antioxidant defenses, plays a pivotal role in the pathogenesis of major diseases, including cardiovascular disorders, diabetes, cancer, and neurodegenerative conditions. ROS, as natural metabolic byproducts, have been shown to damage nucleic acids, proteins, and lipids through mechanisms such as DNA mutations, lipid peroxidation, and altered post-translational modifications, ultimately compromising cellular integrity. Prolonged oxidative conditions have been shown to exacerbate these effects, disrupting critical pathways such as apoptosis, autophagy, and fibrosis. For instance, mitochondrial ROS activate the NLRP3 inflammasome to drive pyroptosis, while TGF-β and ROS form a self-amplifying loop that accelerates fibrotic progression. Furthermore, mitochondrial oxidative stress has been demonstrated to induce ferroptosis via the NRF2-ARE pathway, thereby emphasizing the multifaceted role of ROS in disease mechanisms.

However, controversies persist regarding the net impact of ROS modulation. While ROS scavenging is beneficial in chronic diseases like diabetes (Zhang et al., 2020), excessive antioxidant supplementation may disrupt redox homeostasis, as evidenced by increased cancer risk in vitamin E trials (Jiang, 2024). Moreover, low-level ROS induction via exercise (“mitohormesis”) enhances endogenous defense systems (Kang et al., 2021), contrasting with pathological ROS cascades. This duality necessitates context-specific therapeutic strategies—for instance, pro-oxidant approaches in cancer versus antioxidant interventions in neurodegeneration (Poprac et al., 2017). Therefore, engaging in a more thorough discussion of the controversial or contradictory data arising in the field of oxidative stress research will help to develop a comprehensive perspective. Despite advances in detection methods, there are still significant limitations in terms of reproducibility and clinical applicability. Key challenges include a lack of specificity, where non-specific reactions (e.g., interference from ascorbic acid in the Folin-Ciocalteu assay) can lead to an overestimation of antioxidant capacity; issues with sensitivity due to kinetic discrepancies (e.g., confounding stoichiometry in ORAC resulting from area-under-the-curve integration) and inherent probe limitations (e.g., the pH dependency of fluorescein); and inadequate standardization, as heterogeneous protocols (e.g., the use of arbitrary timepoints in the TEAC assay) impede reliable cross-study comparisons.

Antioxidants, which include both enzymatic (e.g., SOD, CAT) and non-enzymatic agents (e.g., ALA, polyphenols), counteract ROS by restoring redox balance and modulating inflammatory and apoptotic pathways. Phenolic compounds exhibit dual functionality, inhibiting lipoprotein oxidation and suppressing NF-κB-mediated inflammation. In contrast, essential oils target VEGF and apoptosis across a range of disease models. Notwithstanding their considerable potential, challenges such as achieving therapeutic concentrations in vivo and tissue-specific delivery impede clinical translation. Nanotechnology-driven strategies effectively tackle fundamental challenges in antioxidant therapy. Liposomal encapsulation significantly enhances pharmacokinetic profiles and enables site-specific accumulation of antioxidants, exemplified by quercetin delivery for atherosclerosis management (Luo et al., 2022). Furthermore, polymeric nanoparticles facilitate blood-brain barrier penetration and central nervous system (CNS) delivery; notably, SOD-loaded PLGA nanoparticles mitigate oxidative neuronal death (Biswas et al., 2025). Mitochondria-targeted antioxidant conjugates further illustrate the precision achievable through these nanoscale interventions (Cheng et al., 2019). Nanocarriers, including liposomes, polymer nanoparticles, inorganic nanoparticles, and organic/inorganic hybrid nanoparticles, represent a promising strategy for enhancing drug delivery. This approach aims to improve therapeutic efficacy while reducing side effects. The employment of detection methodologies, encompassing ORAC, DPPH, and FRAP assays, facilitates the establishment of standardized measures of antioxidant capacity. Concurrently, the utilization of advanced platforms, such as nanoparticle-based chemiluminescence, enables the real-time analysis of biomarkers. Nevertheless, it is imperative to harmonize these methodologies across studies to ensure reproducibility and clinical relevance.

Translational research must prioritize the integration of molecular insights with therapeutic innovation. Combinatorial strategies that target the generation of ROS, such as NADPH oxidase inhibitors, and the depletion of antioxidants, including glutathione precursors, may yield synergistic benefits. To this end, the necessity for longitudinal studies has been underscored, particularly in aging populations where there is a concomitant decline in NRF2-mediated defenses. The application of personalized approaches informed by tissue-specific redox dynamics—such as mitochondrial stress in cancer or ROS-TGF-β interactions in fibrosis—has the potential to refine interventions. For instance, the disruption of ferroptosis pathways or ROS-TGF-β feedback loops has the potential to impede the progression of the disease.

Despite the advances made, limitations remain. Secondary oxidative stress is a common occurrence in disease, often reducing the efficacy of standalone antioxidant therapies. The process of aging has been shown to diminish the efficacy of NRF2 activation, thereby complicating treatment outcomes for elderly patients. A review of global health data underscores the gravity of the situation: cardiovascular diseases have become the leading cause of global mortality, accounting for nearly 18 million deaths annually (Roth et al., 2020). The total economic burden of cardiovascular diseases is estimated at US$177.5 billion per year (GBD 2019 Diseases and Injuries Collaborators, 2020). According to the World Health Organization’s International Agency for Research on Cancer, 19.29 million new cancer cases and 9.7 million cancer-related deaths were recorded globally in 2022 (Bray et al., 2024). Studies project that cancer will incur US$25 trillion in economic losses worldwide between 2020 and 2050 (Chen et al., 2023). The global prevalence of diabetes continues to rise, with 536.6 million affected individuals in 2021; this figure is projected to reach 783.2 million by 2045. Healthcare expenditures related to diabetes reached US$966 billion in the same year and are expected to rise to US$1.054 trillion by 2045 (Sun et al., 2022). Among populations aged 65 years and older, Alzheimer’s disease exhibits a global prevalence of 6.20%, with incidence rates doubling every 5 years. Direct medical costs associated with Alzheimer’s disease totaled US$1.3 trillion in 2022 and are predicted to exceed US$2.08 trillion by 2050 (Wong, 2020). Therefore, it is urgent to adopt oxidative stress-targeted therapies to alleviate the social and economic burden.

In summary, oxidative stress is a core disease mechanism and promotes interdisciplinary efforts to coordinate diagnostic, therapeutic, and mechanistic research. The future agenda entails the standardization of testing protocols, the development of combination therapies, and the advancement of personalized approaches grounded in tissue-specific redox biology. Addressing these challenges will translate redox science into clinical solutions and ultimately reduce the global burden of oxidative stress-related diseases. Future research endeavors should encompass a comprehensive investigation spanning from preclinical studies to clinical trials. Such efforts may advance along three critical dimensions: elucidating the precise underlying mechanisms, characterizing the dynamic behavior of biomarkers, and addressing patient heterogeneity. Priority should be given to selecting therapeutic targets supported by robust preclinical evidence, establishing a systematic biomarker framework, and stratifying potential beneficiaries based on oxidative stress profiles to facilitate individualized and precise treatment strategies. Evaluations should be conducted across various clinical trial phases-including Phase I, Phase II, Phase IIb, and Phase III-to tailor antioxidant therapies to specific disease subtypes, ranging from simple antioxidant interventions to combination therapies. Methodologically, employing randomized controlled trials with high evidentiary standards, longitudinal cohort studies, and umbrella platform trial designs is recommended. Furthermore, the integration of advanced technologies, such as artificial intelligence, holds promise for accelerating the advancement of precision medicine within this domain.

Author contributions

QG: Writing – original draft. LJ: Writing – original draft. YS: Writing – original draft. XA: Writing – original draft, Software. WS: Writing – original draft, Software. ST: Project administration, Writing – original draft. XK: Project administration, Writing – original draft. XZ: Writing – original draft, Conceptualization. ZL: Writing – original draft, Conceptualization. CL: Conceptualization, Writing – original draft. HJ: Writing – review and editing. FL: Writing – review and editing.

Funding

The author(s) declare that financial support was received for the research and/or publication of this article. This study is sponsored by the National Natural Science Foundation of China (Project No. T2341018), the High Level Chinese Medical Hospital Promotion Proiect (Project No. HLCMHPP2023084), the Clinical Research Center Construction Project of Guang’anmen Hospital, CACMS (Project No. 2022LYJSZX03), the Science and Technology Innovation Project of the Chinese Academy of Traditional Chinese Medicine (Project No. CI2023C049YLL).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Addo, P. W., Poudineh, Z., Shearer, M., Taylor, N., Macpherson, S., Raghavan, V., et al. (2023). Relationship between total antioxidant capacity, cannabinoids and terpenoids in hops and cannabis. Plants (Basel) 12, 1225. doi:10.3390/plants12061225

PubMed Abstract | CrossRef Full Text | Google Scholar

Ahmadi, A., Jamialahmadi, T., and Sahebkar, A. (2022). Polyphenols and atherosclerosis: a critical review of clinical effects on LDL oxidation. Pharmacol. Res. 184, 106414. doi:10.1016/j.phrs.2022.106414

PubMed Abstract | CrossRef Full Text | Google Scholar

Ajith, T. A. (2020). Alpha-lipoic acid: a possible pharmacological agent for treating dry eye disease and retinopathy in diabetes. Clin. Exp. Pharmacol. Physiol. 47, 1883–1890. doi:10.1111/1440-1681.13373

PubMed Abstract | CrossRef Full Text | Google Scholar

Alam, N., Bristi, N. C., and Rafiquzzaman, M. (2013). Review on in vivo and in vitro methods evaluation of antioxidant activity. Saudi Pharm. J. 21, 143–152. doi:10.1016/j.jsps.2012.05.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Amorati, R., and Valgimigli, L. (2015). Advantages and limitations of common testing methods for antioxidants. Free Radic. Res. 49, 633–649. doi:10.3109/10715762.2014.996146

PubMed Abstract | CrossRef Full Text | Google Scholar

Apak, R., Calokerinos, A., Gorinstein, S., Segundo, M. A., Hibbert, D. B., Gülçin, İ., et al. (2022). Methods to evaluate the scavenging activity of antioxidants toward reactive oxygen and nitrogen species (IUPAC Technical Report). Pure Appl. Chem. 94, 87–144. doi:10.1515/pac-2020-0902

CrossRef Full Text | Google Scholar

Arancibia-Riveros, C., Domínguez-López, I., Tresserra-Rimbau, A., Guo, X., Estruch, R., Martínez-González , M., et al. (2023). Total urinary polyphenol excretion: a biomarker of an anti-inflammatory diet and metabolic syndrome status. Am. J. Clin. Nutr. 117, 814–822. doi:10.1016/j.ajcnut.2022.12.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Avila, J., Wandosell, F., and Hernández, F. (2010). Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors. Expert Rev. Neurother. 10, 703–710. doi:10.1586/ern.10.40

PubMed Abstract | CrossRef Full Text | Google Scholar

Aydın Kurç, M., Orak, H. H., Gülen, D., Caliskan, H., Argon, M., and Sabudak, T. (2023). Antimicrobial and antioxidant efficacy of the lipophilic extract of Cirsium vulgare. Molecules 28, 7177. doi:10.3390/molecules28207177

PubMed Abstract | CrossRef Full Text | Google Scholar

Azedi, F., Tavakol, S., Ketabforoush, A., Khazaei, G., Bakhtazad, A., Mousavizadeh, K., et al. (2022). Modulation of autophagy by melatonin via sirtuins in stroke: from mechanisms to therapies. Life Sci. 307, 120870. doi:10.1016/j.lfs.2022.120870

PubMed Abstract | CrossRef Full Text | Google Scholar

Bai, R., Guo, J., Ye, X. Y., Xie, Y., and Xie, T. (2022). Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease. Ageing Res. Rev. 77, 101619. doi:10.1016/j.arr.2022.101619

PubMed Abstract | CrossRef Full Text | Google Scholar

Baliyan, S., Mukherjee, R., Priyadarshini, A., Vibhuti, A., Gupta, A., Pandey, R. P., et al. (2022). Determination of antioxidants by DPPH radical scavenging activity and quantitative phytochemical analysis of Ficus religiosa. Molecules 27, 1326. doi:10.3390/molecules27041326

PubMed Abstract | CrossRef Full Text | Google Scholar

Banday, J. A., Rather, Z. U., Yatoo, G. N., Hajam, M. A., Bhat, S. A., Santhanakrishnan, V. P., et al. (2022). Gas chromatographic-mass spectrometric analysis, antioxidant, antiproliferative and antibacterial activities of the essential oil of Prangospabularia. Microb. Pathog. 166, 105540. doi:10.1016/j.micpath.2022.105540

PubMed Abstract | CrossRef Full Text | Google Scholar

Benzie, I. F. F., and Strain, J. J. (1999). Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Method Enzymol. 299, 15–27. doi:10.1016/s0076-6879(99)99005-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Biswas, A., Hivare, P., Solanki, R., Gupta, S., and Bhatia, D. (2025). Applications of bionanomaterials in neurodegenerative diseases. Mater. Adv. 12, 3785–3804. doi:10.1039/d4ma01215a

CrossRef Full Text | Google Scholar

Bondet, V., Brand-Williams, W., and Berset, C. (1997). Kinetics and mechanisms of antioxidant activity using the DPPH free radical method. Leb. Wissen. Technol. 30, 609–615. doi:10.1006/fstl.1997.0240

CrossRef Full Text | Google Scholar

Bordt, E. A., Zhang, N., Waddell, J., and Polster, B. M. (2022). The non-specific Drp1 inhibitor mdivi-1 has modest biochemical antioxidant activity. Antioxidants (Basel) 11, 450. doi:10.3390/antiox11030450

PubMed Abstract | CrossRef Full Text | Google Scholar

Brand-Williams, W., Cuvelier, M. E., and Berset, C. (1995). Use of a free radical method to evaluate antioxidant activity. Leb. Wissen. Technol. 28, 25–30. doi:10.1016/s0023-6438(95)80008-5

CrossRef Full Text | Google Scholar

Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263. doi:10.3322/caac.21834

PubMed Abstract | CrossRef Full Text | Google Scholar

Bungau, S. G., Vesa, C. M., Bustea, C., Purza, A. L., Tit, D. M., Brisc, M. C., et al. (2023). Antioxidant and Hypoglycemic potential of essential oils in diabetes mellitus and its complications. Int. J. Mol. Sci. 24, 16501. doi:10.3390/ijms242216501

PubMed Abstract | CrossRef Full Text | Google Scholar

Celik, S. E., Özyürek, M., Güçlü, K., and Apak, R. (2010). Solvent effects on the antioxidant capacity of lipophilic and hydrophilic antioxidants measured by CUPRAC, ABTS/Persulphate and FRAP methods. Talanta 81, 1300–1309. doi:10.1016/j.talanta.2010.02.025

PubMed Abstract | CrossRef Full Text | Google Scholar

Chaney, A., Williams, S. R., and Boutin, H. (2019). In vivo molecular imaging of neuroinflammation in Alzheimer's disease. J. Neurochem. 149, 438–451. doi:10.1111/jnc.14615

PubMed Abstract | CrossRef Full Text | Google Scholar

Chen, S., Cao, Z., Prettner, K., Kuhn, M., Yang, J., Jiao, L., et al. (2023). Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 9, 465–472. doi:10.1001/jamaoncol.2022.7826

PubMed Abstract | CrossRef Full Text | Google Scholar

Cheng, Y., Liu, D. Z., Zhang, C. X., Cui, H., Liu, M., Zhang, B. L., et al. (2019). Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia-reperfusion injury through a multistage continuous targeted strategy. Nanomedicine. 16, 236–249. doi:10.1016/j.nano.2018.12.014

PubMed Abstract | CrossRef Full Text | Google Scholar

Chiefa, F., Tedeschi, P., Cescon, M., Costa, V., Sarti, E., Salgado-Ramos, M., et al. (2024). Nutrients and Quality Aspects Characterizing Ostrea edulis Cultivated in Valli di Comacchio (Northern Italy) Across Different Seasons. Molecules 29, 5546. doi:10.3390/molecules29235546

PubMed Abstract | CrossRef Full Text | Google Scholar

Chochevska, M., Jančovska Seniceva, E., Veličkovska, S. K., Naumova-Leţia, G., Mirčeski, V., Rocha, J. M. F., et al. (2021). Electrochemical Determination of antioxidant capacity of traditional homemade fruit vinegars produced with double Spontaneous Fermentation. Microorganisms 9, 1946. doi:10.3390/microorganisms9091946

PubMed Abstract | CrossRef Full Text | Google Scholar

Costa, R., Shah, A. N., Santa-Maria, C. A., Cruz, M. R., Mahalingam, D., Carneiro, B. A., et al. (2017). Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: new discoveries and practical insights for drug development. Cancer Treat. Rev. 53, 111–119. doi:10.1016/j.ctrv.2016.12.010

PubMed Abstract | CrossRef Full Text | Google Scholar

de Araúj, F. Y. R., Chaves Filho, A. J. M., Nunes, A. M., DE Oliveira, G. V., Gomes, P. X. L., Vasconcelos, G. S., et al. (2021). Involvement of anti-inflammatory, antioxidant, and BDNF up-regulating properties in the antipsychotic-like effect of the essential oil of Alpinia zerumbet in mice: a comparative study with olanzapine. Metab. Brain Dis. 36, 2283–2297. doi:10.1007/s11011-021-00821-5

PubMed Abstract | CrossRef Full Text | Google Scholar

DE Sousa, D. P., Damasceno, R. O. S., Amorati, R., Elshabrawy, H. A., DE Castro, R. D., Bezerra, D. P., et al. (2023). Essential oils: Chemistry and pharmacological activities. Biomolecules 13, 1144. doi:10.3390/biom13071144

PubMed Abstract | CrossRef Full Text | Google Scholar

Dellali, M., Hedfi, A., Ali, M. B., Noureldeen, A., Darwish, H., Beyrem, H., et al. (2021). Multi-biomarker approach in Mytilus galloprovincialis and Ruditapes decussatus as a predictor of pelago-benthic responses after exposure to Benzo[a]Pyrene. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 249, 109141. doi:10.1016/j.cbpc.2021.109141

PubMed Abstract | CrossRef Full Text | Google Scholar

Di Pierro, D., Ciaccio, C., Sbardella, D., Tundo, G. R., Bernardini, R., Curatolo, P., et al. (2020). Effects of oral administration of common antioxidant supplements on the energy metabolism of red blood cells. Attenuation of oxidative stress-induced changes in Rett syndrome erythrocytes by CoQ10. Mol. Cell Biochem. 463, 101–113. doi:10.1007/s11010-019-03633-5

PubMed Abstract | CrossRef Full Text | Google Scholar

Diseases and Injuries Collaborators (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 396, 1204–1222. doi:10.1016/S0140-6736(20)30925-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Dogaru, C. B., Muscurel, C., Duță, C., and Stoian, I. (2023). Alphabet selenoproteins: their characteristics and physiological roles. Int. J. Mol. Sci. 24, 15992. doi:10.3390/ijms242115992

PubMed Abstract | CrossRef Full Text | Google Scholar

Drews, G., Krippeit-Drews, P., and Düfer, M. (2010). Oxidative stress and beta-cell dysfunction. Pflugers Arch. 460, 703–718. doi:10.1007/s00424-010-0862-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Duni, A., Liakopoulos, V., Roumeliotis, S., Peschos, D., and Dounousi, E. (2019). Oxidative stress in the pathogenesis and Evolution of chronic kidney disease: Untangling Ariadne's Thread. Int. J. Mol. Sci. 20, 3711. doi:10.3390/ijms20153711

PubMed Abstract | CrossRef Full Text | Google Scholar

Elbahnaswy, S., and Elshopakey, G. E. (2024). Recent progress in practical applications of a potential carotenoid astaxanthin in aquaculture industry: a review. Fish. Physiol. Biochem. 50, 97–126. doi:10.1007/s10695-022-01167-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Elveny, M., Akhmadeev, R., Dinari, M., Abdelbasset, W. K., Bokov, D. O., and Jafari, M. M. M. (2021). Implementing PSO-ELM model to approximate trolox equivalent antioxidant capacity as one of the most important biological properties of food. Biomed. Res. Int. 2021, 3805748. doi:10.1155/2021/3805748

PubMed Abstract | CrossRef Full Text | Google Scholar

Ercan, S., Aktas, A., and Kemaloglu, M. S. (2021). Antioxidative effects of alpha-lipoic acid in spinal cord injury an experimental rat model. Ann. Ital. Chir. 92, 98–102.

PubMed Abstract | Google Scholar

Fasipe, B., Faria, A., and Laher, I. (2023). Potential for novel therapeutic Uses of alpha lipoic acid. Curr. Med. Chem. 30, 3942–3954. doi:10.2174/0929867329666221006115329

PubMed Abstract | CrossRef Full Text | Google Scholar

Fredes, C., Parada, A., Salinas, J., and Robert, P. (2020). Phytochemicals and traditional Use of two southernmost Chilean Berry fruits: Murta (ugni molinae turcz) and calafate (berberis buxifolia lam.). Foods 9, 54. doi:10.3390/foods9010054

PubMed Abstract | CrossRef Full Text | Google Scholar

GarcíA-NicoláS, M., Ledesma-Escobar, C. A., and Priego-Capote, F. (2023). Spatial distribution and antioxidant activity of extracts from citrus fruits. Antioxidants (Basel) 12, 781. doi:10.3390/antiox12040781

PubMed Abstract | CrossRef Full Text | Google Scholar

Geiszt, M., Kopp, J. B., Várnai, P., and Leto, T. L. (2000). Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl. Acad. Sci. U. S. A. 97, 8010–8014. doi:10.1073/pnas.130135897

PubMed Abstract | CrossRef Full Text | Google Scholar

Ghiselli, A., Serafini, M., Maiani, G., Azzini, E., and Ferro-Luzzi, A. (1995). A fluorescence-based method for measuring total plasma antioxidant capability. Free Radic. Biol. Med. 18, 29–36. doi:10.1016/0891-5849(94)00102-p

PubMed Abstract | CrossRef Full Text | Google Scholar

Glorieux, C., Liu, S., Trachootham, D., and Huang, P. (2024). Targeting ROS in cancer: rationale and strategies. Nat. Rev. Drug Discov. 23, 583–606. doi:10.1038/s41573-024-00979-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Godoy, G., Travassos, P. B., Antunes, M. M., Iwanaga, C. C., Sá-Nakanishi, A. B., Curi, R., et al. (2022). Strenuous swimming raises blood non-enzymatic antioxidant capacity in rats. Braz J. Med. Biol. Res. 55, e11891. doi:10.1590/1414-431X2022e11891

PubMed Abstract | CrossRef Full Text | Google Scholar

Guan, C., Zhou, X., Li, H., Ma, X., and Zhuang, J. (2022). NF-κB inhibitors gifted by nature: the anticancer promise of polyphenol compounds. Biomed. Pharmacother. 156, 113951. doi:10.1016/j.biopha.2022.113951

PubMed Abstract | CrossRef Full Text | Google Scholar

Gulcin, I. (2008). Measurement of antioxidant ability of melatonin and serotonin by the DMPD and CUPRAC methods as trolox equivalent. J. Enzyme Inhib. Med. Chem. 23, 871–876. doi:10.1080/14756360701626223

PubMed Abstract | CrossRef Full Text | Google Scholar

Gulcin, I. (2020). Antioxidants and antioxidant methods: an updated Overview. Arch. Toxicol. 94, 651–715. doi:10.1007/s00204-020-02689-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Gulcin, I., Elmastas, M., and Aboul-Enein, H. Y. (2007). Determination of antioxidant and radical scavenging activity of basil (Ocimum basilicum L. Family lamiaceae) assayed by different methodologies. Phytother. Res. 21, 354–361. doi:10.1002/ptr.2069

PubMed Abstract | CrossRef Full Text | Google Scholar

Gullcin, I., and Daştan, A. (2007). Synthesis of Dimeric phenol derivatives and determination of in vitro antioxidant and radical scavenging activities. J. Enzyme Inhib. Med. Chem. 22, 685–695. doi:10.1080/14756360601164903

PubMed Abstract | CrossRef Full Text | Google Scholar

Guo, X., Tresserra-Rimbau, A., Estruch, R., MartíNEZ-GonzáLEZ, M. A., Medina-RemóN, A., CastañER, O., et al. (2016). Effects of polyphenol, measured by a biomarker of total polyphenols in urine, on cardiovascular risk factors after a long-term Follow-up in the PREDIMED study. Oxid. Med. Cell Longev. 2016, 2572606. doi:10.1155/2016/2572606

PubMed Abstract | CrossRef Full Text | Google Scholar

Hajieva, P., Abrosimov, R., Kunath, S., and Moosmann, B. (2023). Antioxidant and prooxidant modulation of lipid peroxidation by integral membrane proteins. Free Radic. Res. 57, 105–114. doi:10.1080/10715762.2023.2201391

PubMed Abstract | CrossRef Full Text | Google Scholar

Haldar, S., Chia, S. C., Lee, S. H., Lim, J., Leow, M. K., Chan, E. C. Y., et al. (2019). Polyphenol-rich curry made with mixed spices and vegetables benefits glucose homeostasis in Chinese males (Polyspice Study): a dose-response randomized controlled crossover trial. Eur. J. Nutr. 58, 301–313. doi:10.1007/s00394-017-1594-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Hariharan, S., and Dharmaraj, S. (2020). Selenium and selenoproteins: it's role in regulation of inflammation. Inflammopharmacology 28, 667–695. doi:10.1007/s10787-020-00690-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Hearn, A. S., Tu, C., Nick, H. S., and Silverman, D. N. (1999). Characterization of the product-inhibited complex in catalysis by human manganese superoxide dismutase. J. Biol. Chem. 274, 24457–24460. doi:10.1074/jbc.274.35.24457

PubMed Abstract | CrossRef Full Text | Google Scholar

Henriksen, E. J., Diamond-Stanic, M. K., and Marchionne, E. M. (2011). Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 51, 993–999. doi:10.1016/j.freeradbiomed.2010.12.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Hillman, A. R., and Uhranowsky, K. (2021). Acute Ingestion of Montmorency Tart cherry reduces Serum uric acid but has no impact on high sensitivity C-reactive protein or oxidative capacity. Plant Foods Hum. Nutr. 76, 83–89. doi:10.1007/s11130-021-00879-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, D., Ou, B., Hampsch-Woodill, M., Flanagan, J. A., and Deemer, E. K. (2002). Development and Validation of oxygen radical absorbance capacity assay for lipophilic antioxidants using randomly methylated beta-cyclodextrin as the solubility enhancer. J. Agric. Food Chem. 50, 1815–1821. doi:10.1021/jf0113732

PubMed Abstract | CrossRef Full Text | Google Scholar

Huang, J., Xie, L., Song, A., and Zhang, C. (2022). Selenium status and its antioxidant role in metabolic diseases. Oxid. Med. Cell Longev. 2022, 7009863. doi:10.1155/2022/7009863

PubMed Abstract | CrossRef Full Text | Google Scholar

Iordănescu, O. A., Băla, M., Gligor Pane, D., Zippenfening, S. E., Cugerean, M. I., Petroman, M. I., et al. (2021). A DPPH· kinetic approach on the antioxidant activity of various parts and Ripening levels of papaya (Carica papaya L.) Ethanolic extracts. Plants (Basel) 10, 1679. doi:10.3390/plants10081679

PubMed Abstract | CrossRef Full Text | Google Scholar

Iqbal, K., Liu, F., and Gong, C. X. (2014). Alzheimer disease therapeutics: focus on the disease and not just plaques and tangles. Biochem. Pharmacol. 88, 631–639. doi:10.1016/j.bcp.2014.01.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Javaid, M. S., Antonic-Baker, A., Pitsillou, E., Liang, J., French, C., Hung, A., et al. (2022). Alpha-lipoic acid analogues in the regulation of redox balance in epilepsy: a molecular docking and simulation study. J. Mol. Graph Model 112, 108116. doi:10.1016/j.jmgm.2021.108116

PubMed Abstract | CrossRef Full Text | Google Scholar

Jiang, Q. (2024). Different roles of tocopherols and tocotrienols in Chemoprevention and treatment of Prostate cancer. Adv. Nutr. 15, 100240. doi:10.1016/j.advnut.2024.100240

PubMed Abstract | CrossRef Full Text | Google Scholar

Jin, Y., Wu, J., Hu, D., Li, J., Zhu, W., Yuan, L., et al. (2023). Gamma-aminobutyric acid-producing Levilactobacillus brevis strains as Probiotics in Litchi Juice Fermentation. Foods 12, 302. doi:10.3390/foods12020302

PubMed Abstract | CrossRef Full Text | Google Scholar

Kamt, S. F., Liu, J., and Yan, L. J. (2023). Renal-protective roles of lipoic acid in kidney disease. Nutrients 15, 1732. doi:10.3390/nu15071732

PubMed Abstract | CrossRef Full Text | Google Scholar

Kang, G. M., Min, S. H., Lee, C. H., Kim, J. Y., Lim, H. S., Choi, M. J., et al. (2021). Mitohormesis in hypothalamic POMC neurons mediates regular exercise-induced high-turnover metabolism. Cell Metab. 33, 334–349.e6. doi:10.1016/j.cmet.2021.01.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Karaman, S., Tutem, E., Başkan, K. S., and Apak, R. (2009). Comparison of total antioxidant capacity and phenolic composition of some apple juices with combined HPLC-CUPRAC assay. Food Chem. 120, 1201–1209. doi:10.1016/j.foodchem.2009.11.065

CrossRef Full Text | Google Scholar

Karim, A., Anwar, F., Saleem, U., Fatima, S., Ismail, T., Obaidullah, A. J., et al. (2023). Administration of α-lipoic acid and silymarin attenuates aggression by modulating endocrine, oxidative stress and inflammatory pathways in mice. Metab. Brain Dis. 38, 2255–2267. doi:10.1007/s11011-023-01258-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Kartau, M., Kartau, J., Pohja, M., and Verkkoniemi-Ahola, A. (2024). Plasma antioxidant potential measured by total radical trapping antioxidant parameter in a cohort of multiple sclerosis patients. Brain Behav. 14, e3377. doi:10.1002/brb3.3377

PubMed Abstract | CrossRef Full Text | Google Scholar

Khan, H., Singh, T. G., Dahiya, R. S., and Abdel-Daim, M. M. (2022). α-Lipoic acid, an organosulfur biomolecule a novel therapeutic agent for neurodegenerative disorders: an mechanistic perspective. Neurochem. Res. 47, 1853–1864. doi:10.1007/s11064-022-03598-w

PubMed Abstract | CrossRef Full Text | Google Scholar

Kimatu, B. M., Zhao, L., Biao, Y., Ma, G., Yang, W., Pei, F., et al. (2017). Antioxidant potential of edible mushroom (Agaricus bisporus) protein hydrolysates and their ultrafiltration fractions. Food Chem. 230, 58–67. doi:10.1016/j.foodchem.2017.03.030

PubMed Abstract | CrossRef Full Text | Google Scholar

Kuerban, A., AL-Malki, A. L., Kumosani, T. A., Sheikh, R. A., AL-Abbasi, F. A. M., Alshubaily, F. A., et al. (2020). Identification, protein antiglycation, antioxidant, antiproliferative, and molecular docking of novel bioactive peptides produced from hydrolysis of Lens culinaris. J. Food Biochem. 44, e13494. doi:10.1111/jfbc.13494

PubMed Abstract | CrossRef Full Text | Google Scholar

Lambeth, J. D. (2004). NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181–189. doi:10.1038/nri1312

PubMed Abstract | CrossRef Full Text | Google Scholar

Lau, L. F., Seymour, P. A., Sanner, M. A., and Schachter, J. B. (2002). Cdk5 as a drug target for the treatment of Alzheimer's disease. J. Mol. Neurosci. 19, 267–273. doi:10.1385/JMN:19:3:267

PubMed Abstract | CrossRef Full Text | Google Scholar

Laveriano-Santos, E. P., Parilli-Moser, I., RamíREZ-Garza, S. L., Tresserra-Rimbau, A., Storniolo, C. E., Ruiz-LeóN, A. M., et al. (2020). Polyphenols in urine and cardiovascular risk factors: a cross-sectional analysis reveals gender differences in Spanish adolescents from the SI! Program. Antioxidants (Basel) 9, 910. doi:10.3390/antiox9100910

PubMed Abstract | CrossRef Full Text | Google Scholar

Lee, H. J., Lee, S. H., Hong, S. K., Gil, B. I., and Lee, K. A. (2024). In vitro biological activities of hesperidin-related compounds with different solubility. Antioxidants (Basel) 13, 727. doi:10.3390/antiox13060727

PubMed Abstract | CrossRef Full Text | Google Scholar

Liang, Y., and Were, L. (2020). Cysteine's effects on chlorogenic acid quinone induced greening and browning: mechanism and effect on antioxidant reducing capacity. Food Chem. 309, 125697. doi:10.1016/j.foodchem.2019.125697

PubMed Abstract | CrossRef Full Text | Google Scholar

Libby, P. (2021). The changing landscape of atherosclerosis. Nature 592, 524–533. doi:10.1038/s41586-021-03392-8

PubMed Abstract | CrossRef Full Text | Google Scholar

Liu, X., Yang, L., Zhang, G., and Ling, J. (2023). Neuroprotective effects of phenolic antioxidant Tert-butylhydroquinone (tBHQ) in brain diseases. Mol. Neurobiol. 60, 4909–4923. doi:10.1007/s12035-023-03370-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Luo, X., Weng, X., Bao, X., Bai, X., Lv, Y., ZhANG, S., et al. (2022). A novel anti-atherosclerotic mechanism of quercetin: competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis. Redox Biol. 57, 102511. doi:10.1016/j.redox.2022.102511

PubMed Abstract | CrossRef Full Text | Google Scholar

Mamri, S., Daoudi, N. E., Baraich, A., Ouahhoud, S., Khoulati, A., Choukri, M., et al. (2024). Comprehensive analysis of bioactive compounds in Crocus sativus stamens extracts by HPLC-DAD: investigating antidiabetic activity via in vitro, in vivo, and molecular docking simulation. Front. Chem. 12, 1419120. doi:10.3389/fchem.2024.1419120

PubMed Abstract | CrossRef Full Text | Google Scholar

Mapuskar, K. A., Flippo, K. H., Schoenfeld, J. D., Riley, D. P., Strack, S., Hejleh, T. A., et al. (2017). Mitochondrial superoxide increases age-associated susceptibility of human dermal fibroblasts to radiation and chemotherapy. Cancer Res. 77, 5054–5067. doi:10.1158/0008-5472.CAN-17-0106

PubMed Abstract | CrossRef Full Text | Google Scholar

Mapuskar, K. A., Pulliam, C. F., Tomanek-Chalkley, A., Rastogi, P., Wen, H., Dayal, S., et al. (2024). The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury. Redox Biol. 70, 103022. doi:10.1016/j.redox.2023.103022

PubMed Abstract | CrossRef Full Text | Google Scholar

Meyer, B. R., White, H. M., Mccormack, J. D., and Niemeyer, E. D. (2023). Catechin composition, phenolic content, and antioxidant properties of commercially-available bagged, gunpowder, and matcha green teas. Plant Foods Hum. Nutr. 78, 662–669. doi:10.1007/s11130-023-01121-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Miller, N. J., Rice-Evans, C., Davies, M. J., Gopinathan, V., and Milner, A. (1993). A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84, 407–412. doi:10.1042/cs0840407

PubMed Abstract | CrossRef Full Text | Google Scholar

Mishra, A., Reeta, K. H., Sarangi, S. C., Maiti, R., and Sood, M. (2022). Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial. Psychopharmacol. Berl. 239, 3525–3535. doi:10.1007/s00213-022-06225-2

PubMed Abstract | CrossRef Full Text | Google Scholar

Moroz, N., Tong, M., Longato, L., Xu, H., and DE LA Monte, S. M. (2008). Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J. Alzheimers Dis. 15, 29–44. doi:10.3233/jad-2008-15103

PubMed Abstract | CrossRef Full Text | Google Scholar

Motto, A. E., Lawson-Evi, P., Bakoma, B., Eklu-Gadegbeku, K., and Aklikokou, K. (2021). Antihyperlipidemic and antioxidant properties of hydro-alcoholic extracts from Anogeissus leiocarpus (Combretaceae). Heliyon 7, e06648. doi:10.1016/j.heliyon.2021.e06648

PubMed Abstract | CrossRef Full Text | Google Scholar

Multescu, M., Marinas, I. C., Susman, I. E., and Belc, N. (2022). Byproducts (flour, meals, and groats) from the vegetable oil industry as a potential source of antioxidants. Foods 11, 253. doi:10.3390/foods11030253

PubMed Abstract | CrossRef Full Text | Google Scholar

Murphy, M. P. (2012). Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. Antioxid. Redox Signal 16, 476–495. doi:10.1089/ars.2011.4289

PubMed Abstract | CrossRef Full Text | Google Scholar

Naderi, N., Darmishonnejad, Z., Tavalaee, M., and Nasr-Esfahani, M. H. (2023). The effect of alpha-lipoic acid on sperm functions in rodent models for male infertility: a systematic review. Life Sci. 323, 121383. doi:10.1016/j.lfs.2023.121383

PubMed Abstract | CrossRef Full Text | Google Scholar

Nadia, B., Mesli, F., Zahra, B. F., Merad-Boussalah, N., Radja, A., Muselli, A., et al. (2022). Chemical composition variability and vascular endothelial growth factor receptors inhibitory activity of Inulaviscosa essential oils from Algeria. J. Biomol. Struct. Dyn. 40, 3462–3480. doi:10.1080/07391102.2020.1847686

PubMed Abstract | CrossRef Full Text | Google Scholar

Napolitano, G., Fasciolo, G., and Venditti, P. (2021). Mitochondrial management of reactive oxygen species. Antioxidants (Basel) 10, 1824. doi:10.3390/antiox10111824

PubMed Abstract | CrossRef Full Text | Google Scholar

Nea, F., Bitchi, M. B., Genva, M., Ledoux, A., Tchinda, A. T., Damblon, C., et al. (2021). Phytochemical investigation and biological activities of Lantana rhodesiensis. Molecules 26, 846. doi:10.3390/molecules26040846

PubMed Abstract | CrossRef Full Text | Google Scholar

Neculai, A. M., Stanciu, G., and Mititelu, M. (2023). Determination of active ingredients, mineral composition and antioxidant properties of hydroalcoholic macerates of Vinca minor L. Plant from the dobrogea area. Molecules 28, 5667. doi:10.3390/molecules28155667

PubMed Abstract | CrossRef Full Text | Google Scholar

Nilsson, M. I., and Tarnopolsky, M. A. (2019). Mitochondria and aging-the role of exercise as a countermeasure. Biol. (Basel) 8, 40. doi:10.3390/biology8020040

PubMed Abstract | CrossRef Full Text | Google Scholar

Nyayiru Kannaian, U. P., Edwin, J. B., Rajagopal, V., Nannu Shankar, S., and Srinivasan, B. (2020). Phytochemical composition and antioxidant activity of coconut cotyledon. Heliyon 6, e03411. doi:10.1016/j.heliyon.2020.e03411

PubMed Abstract | CrossRef Full Text | Google Scholar

Odeh, D., Oršolić, N., Berendika, M., Đikić, D., Domjanić Drozdek, S., Balbino, S., et al. (2022). Antioxidant and anti-atherogenic activities of essential oils from myrtus communis L. And laurus nobilis L. In rat. Nutrients 14, 1465. doi:10.3390/nu14071465

PubMed Abstract | CrossRef Full Text | Google Scholar

Ojo, O. O., and Leake, D. S. (2021). Vitamins E and C do not effectively inhibit low density lipoprotein oxidation by ferritin at lysosomal pH. Free Radic. Res. 55, 525–534. doi:10.1080/10715762.2021.1964494

PubMed Abstract | CrossRef Full Text | Google Scholar

Oraebosi, M. I., Olurishe, T. O., Anafi, S. B., and Bisalla, M. (2022). Diurnal efficacy of alpha-lipoic acid/nifedipine/glimepiride combination mitigates diabetic neuropathies in rats. Ann. Pharm. Fr. 80, 291–300. doi:10.1016/j.pharma.2021.09.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Orellana-Paucar, A. M. (2024). Turmeric essential oil constituents as potential drug candidates: a comprehensive overview of their individual bioactivities. Molecules 29, 4210. doi:10.3390/molecules29174210

PubMed Abstract | CrossRef Full Text | Google Scholar

Ou, B., Hampsch-Woodill, M., and Prior, R. L. (2001). Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J. Agric. Food Chem. 49, 4619–4626. doi:10.1021/jf010586o

PubMed Abstract | CrossRef Full Text | Google Scholar

Ou, B., Hampsch-Woodill, M., Flanagan, J., Deemer, E. K., Prior, R. L., and Huang, D. (2002). Novel fluorometric assay for hydroxyl radical prevention capacity using fluorescein as the probe. J. Agric. Food Chem. 50, 2772–2777. doi:10.1021/jf011480w

PubMed Abstract | CrossRef Full Text | Google Scholar

Ou, B., Huang, D., Hampsch-Woodill, M., Flanagan, J. A., and Deemer, E. K. (2002). Analysis of antioxidant activities of common vegetables employing oxygen radical absorbance capacity (ORAC) and ferric reducing antioxidant power (FRAP) assays: a comparative study. J. Agric. Food Chem. 50, 3122–3128. doi:10.1021/jf0116606

PubMed Abstract | CrossRef Full Text | Google Scholar

Paiva, L., Lima, E., Neto, A. I., and Baptista, J. (2017). Angiotensin I-converting enzyme (ACE) inhibitory activity, antioxidant properties, phenolic content and amino acid profiles of fucus spiralis L. Protein hydrolysate fractions. Mar. Drugs 15, 311. doi:10.3390/md15100311

PubMed Abstract | CrossRef Full Text | Google Scholar

Pala, E. E., Pala, H. G., Ekmekci, S., and Erbas, O. (2022). Vitamin C (Ascorbic acid) protects from neuropathy caused by cisplatin, through enhanced heat shock protein-70 and reduced oxidant effect. Rev. Assoc. Med. Bras. 68, 1017–1022. doi:10.1590/1806-9282.20220032

PubMed Abstract | CrossRef Full Text | Google Scholar

Peifer, M., Fernández-Cuesta, L., Sos, M. L., George, J., Seidel, D., Kasper, L. H., et al. (2012). Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44, 1104–1110. doi:10.1038/ng.2396

PubMed Abstract | CrossRef Full Text | Google Scholar

Pisoschi, A. M., Iordache, F., Stanca, L., Cimpeanu, C., Furnaris, F., Geicu, O. I., et al. (2024). Comprehensive and critical view on the anti-inflammatory and immunomodulatory role of natural phenolic antioxidants. Eur. J. Med. Chem. 265, 116075. doi:10.1016/j.ejmech.2023.116075

PubMed Abstract | CrossRef Full Text | Google Scholar

Polat Kose, L., and Gulcin, İ. (2021). Evaluation of the antioxidant and antiradical properties of some phyto and mammalian lignans. Molecules 26, 7099. doi:10.3390/molecules26237099

PubMed Abstract | CrossRef Full Text | Google Scholar

Polumackanycz, M., Konieczynski, P., Orhan, I. E., Abaci, N., and Viapiana, A. (2022a). Chemical composition, antioxidant and anti-enzymatic activity of golden root (rhodiola rosea L.) commercial samples. Antioxidants (Basel) 11, 919. doi:10.3390/antiox11050919

PubMed Abstract | CrossRef Full Text | Google Scholar

Polumackanycz, M., Petropoulos, S. A., Añibarro-Ortega, M., Pinela, J., Barros, L., Plenis, A., et al. (2022b). Chemical composition and antioxidant properties of common and lemon verbena. Antioxidants (Basel) 11, 2247. doi:10.3390/antiox11112247

PubMed Abstract | CrossRef Full Text | Google Scholar

Poprac, P., Jomova, K., Simunkova, M., Kollar, V., Rhodes, C. J., and Valko, M. (2017). Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol. Sci. 38, 592–607. doi:10.1016/j.tips.2017.04.005

PubMed Abstract | CrossRef Full Text | Google Scholar

Powers, S. K., Deminice, R., Ozdemir, M., Yoshihara, T., Bomkamp, M. P., and Hyatt, H. (2020). Exercise-induced oxidative stress: friend or foe? J. Sport Health Sci. 9, 415–425. doi:10.1016/j.jshs.2020.04.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Prior, R. L., Wu, X., and Schaich, K. (2005). Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J. Agric. Food Chem. 53, 4290–4302. doi:10.1021/jf0502698

PubMed Abstract | CrossRef Full Text | Google Scholar

Pulido, R., Bravo, L., and Saura-Calixto, F. (2000). Antioxidant activity of dietary polyphenols as determined by a modified ferric reducing/antioxidant power assay. J. Agric. Food Chem. 48, 3396–3402. doi:10.1021/jf9913458

PubMed Abstract | CrossRef Full Text | Google Scholar

Pulido, R., Hernández-García, M., and Saura-Calixto, F. (2003). Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur. J. Clin. Nutr. 57, 1275–1282. doi:10.1038/sj.ejcn.1601685

PubMed Abstract | CrossRef Full Text | Google Scholar

Rajagukguk, Y. V., Arnold, M., Sidor, A., Kulczyński, B., Brzozowska, A., Schmidt, M., et al. (2022). Antioxidant activity, probiotic survivability, and sensory properties of a phenolic-rich pulse snack bar enriched with lactiplantibacillus plantarum. Foods 11, 309. doi:10.3390/foods11030309

PubMed Abstract | CrossRef Full Text | Google Scholar

Re, R., Pellegrini, N., Proteggente, A., Pannala, A., Yang, M., and Rice-Evans, C. (1999). Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26, 1231–1237. doi:10.1016/s0891-5849(98)00315-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Ribeiro, F., Alves, A. J., Duarte, J. A., and Oliveira, J. (2010). Is exercise training an effective therapy targeting endothelial dysfunction and vascular wall inflammation? Int. J. Cardiol. 141, 214–221. doi:10.1016/j.ijcard.2009.09.548

PubMed Abstract | CrossRef Full Text | Google Scholar

Rice-Evans, C., and Miller, N. J. (1994). Total antioxidant status in plasma and body fluids. Method Enzymol. 234, 279–293. doi:10.1016/0076-6879(94)34095-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Rita, K., Bernardo, M. A., Silva, M. L., Brito, J., Mesquita, M. F., PintãO, A. M., et al. (2022). Adansonia digitata L. (baobab fruit) effect on postprandial glycemia in healthy adults: a randomized controlled trial. Nutrients 14, 398. doi:10.3390/nu14020398

PubMed Abstract | CrossRef Full Text | Google Scholar

Rosiak, N., Cielecka-Piontek, J., Skibiński, R., Lewandowska, K., Bednarski, W., and Zalewski, P. (2023). Do rutin and quercetin retain their structure and radical scavenging activity after exposure to radiation? Molecules 28, 2713. doi:10.3390/molecules28062713

PubMed Abstract | CrossRef Full Text | Google Scholar

Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., et al. (2020). Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76(25): 2982–3021. doi:10.1016/j.jacc.2020.11.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Roy, S. (2014). Maintenance of genome stability in plants: repairing DNA double strand breaks and chromatin structure stability. Front. Plant Sci. 5, 487. doi:10.3389/fpls.2014.00487

PubMed Abstract | CrossRef Full Text | Google Scholar

Saito, T., Chiku, T., Oka, M., Wada-Kakuda, S., Nobuhara, M., Oba, T., et al. (2021). Disulfide bond formation in microtubule-associated tau protein promotes tau accumulation and toxicity in vivo. Hum. Mol. Genet. 30, 1955–1967. doi:10.1093/hmg/ddab162

PubMed Abstract | CrossRef Full Text | Google Scholar

Salem, Y., Rajha, H. N., Franjieh, D., Hoss, I., Manca, M. L., Manconi, M., et al. (2022). Stability and antioxidant activity of hydro-glyceric extracts obtained from different grape seed varieties incorporated in cosmetic creams. Antioxidants (Basel) 11, 1348. doi:10.3390/antiox11071348

PubMed Abstract | CrossRef Full Text | Google Scholar

Sarmadi, B., Musazadeh, V., Dehghan, P., and Karimi, E. (2023). The effect of cinnamon consumption on lipid profile, oxidative stress, and inflammation biomarkers in adults: an umbrella meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc Dis. 33, 1821–1835. doi:10.1016/j.numecd.2023.03.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Schieber, M., and Chandel, N. S. (2014). ROS function in redox signaling and oxidative stress. Curr. Biol. 24, R453–R462. doi:10.1016/j.cub.2014.03.034

PubMed Abstract | CrossRef Full Text | Google Scholar

Sepúlveda-Loyola, W., DE Castro, L. A., Matsumoto, A. K., Camillo, C. A., Barbosa, D. S., Galvan, C. C. R., et al. (2021). NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD. Heart Lung 50, 184–191. doi:10.1016/j.hrtlng.2020.06.001

PubMed Abstract | CrossRef Full Text | Google Scholar

Shahidi, F., and Zhong, Y. (2015). Measurement of antioxidant activity. J. Funct. Foods. Amst. 18, 757–781. doi:10.1016/j.jff.2015.01.047

CrossRef Full Text | Google Scholar

Shiose, A., Kuroda, J., Tsuruya, K., Hirai, M., Hirakata, H., Naito, S., et al. (2001). A novel superoxide-producing NAD(P)H oxidase in kidney. J. Biol. Chem. 276, 1417–1423. doi:10.1074/jbc.M007597200

PubMed Abstract | CrossRef Full Text | Google Scholar

Shivakumar, A., and Yogendra Kumar, M. S. (2018). Critical review on the analytical mechanistic steps in the evaluation of antioxidant activity. Crit. Rev. Anal. Chem. 48, 214–236. doi:10.1080/10408347.2017.1400423

PubMed Abstract | CrossRef Full Text | Google Scholar

Singal, G., Miller, P. G., Agarwala, V., Li, G., Kaushik, G., Backenroth, D., et al. (2019). Association of patient characteristics and tumor genomics with clinical outcomes among patients with non-small cell lung cancer using a clinicogenomic database. Jama 321, 1391–1399. doi:10.1001/jama.2019.3241

PubMed Abstract | CrossRef Full Text | Google Scholar

Singleton, V. L., and Rossi, J. A. (1965). Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 16, 144–158. doi:10.5344/ajev.1965.16.3.144

CrossRef Full Text | Google Scholar

Singleton, V. L., Orthofer, R., and Lamuela-Raventós, R. M. (1999). Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Method Enzymol. 299, 152–178. doi:10.1016/S0076-6879(99)99017-1

CrossRef Full Text | Google Scholar

Sobhani, S., Tehrani, A. A., Sobhani, G., Fatima, S., Ulloa, L., Motaghinejad, M., et al. (2023). Melatonin protects against titanium oxide-induced neurotoxicity: neurochemical, neurobehavioral, and histopathological evidences. Biol. Trace Elem. Res. 201, 3861–3881. doi:10.1007/s12011-022-03464-4

PubMed Abstract | CrossRef Full Text | Google Scholar

Sohal, R. S. (1993). Aging, cytochrome oxidase activity, and hydrogen peroxide release by mitochondria. Free Radic. Biol. Med. 14, 583–588. doi:10.1016/0891-5849(93)90139-l

PubMed Abstract | CrossRef Full Text | Google Scholar

Somogyi, A., Rosta, K., Pusztai, P., Tulassay, Z., and Nagy, G. (2007). Antioxidant measurements. Physiol. Meas. 28, R41–R55. doi:10.1088/0967-3334/28/4/R01

PubMed Abstract | CrossRef Full Text | Google Scholar

Spagnuolo, C., Moccia, S., Tedesco, I., Crescente, G., Volpe, M. G., Russo, M., et al. (2022). Phenolic extract from extra virgin olive oil induces different anti-proliferative pathways in human bladder cancer cell lines. Nutrients 15, 182. doi:10.3390/nu15010182

PubMed Abstract | CrossRef Full Text | Google Scholar

Stefanou, D. T., Kouvela, M., Stellas, D., Voutetakis, K., Papadodima, O., Syrigos, K., et al. (2022). Oxidative stress and deregulated DNA damage response network in lung cancer patients. Biomedicines 10, 1248. doi:10.3390/biomedicines10061248

PubMed Abstract | CrossRef Full Text | Google Scholar

SuáREZ-Carrillo, A., Álvarez-CóRDOBA, M., Romero-GonzáLEZ, A., TalaveróN-Rey, M., Povea-Cabello, S., Cilleros-Holgado, P., et al. (2023). Antioxidants prevent iron accumulation and lipid peroxidation, but do not correct autophagy dysfunction or mitochondrial bioenergetics in cellular models of BPAN. Int. J. Mol. Sci. 24, 14576. doi:10.3390/ijms241914576

PubMed Abstract | CrossRef Full Text | Google Scholar

Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B. B., et al. (2022). IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119. doi:10.1016/j.diabres.2021.109119

PubMed Abstract | CrossRef Full Text | Google Scholar

Tahar, S., Hamdi, B., Flamini, G., Mehmet, Ö., Duru, M. E., Bruno, M., et al. (2022). Chemical composition, antioxidant and anticholinesterase activity of the essential oil of algerian cachrys sicula L. Nat. Prod. Res. 36, 4094–4102. doi:10.1080/14786419.2021.1969567

PubMed Abstract | CrossRef Full Text | Google Scholar

Tanaka, M., Kaji, K., Nishimura, N., Asada, S., Koizumi, A., Matsuda, T., et al. (2024). Blockade of angiotensin II modulates insulin-like growth factor 1-mediated skeletal muscle homeostasis in experimental steatohepatitis. Biochim. Biophys. Acta Mol. Cell Res. 1871, 119649. doi:10.1016/j.bbamcr.2023.119649

PubMed Abstract | CrossRef Full Text | Google Scholar

Taniguchi, Y., Koga, Y., Fukabori, K., Kawaguchi, R., and Sasaki, S. (2012). OFF-to-ON type fluorescent probe for the detection of 8-oxo-dG in DNA by the Adap-masked ODN probe. Bioorg Med. Chem. Lett. 22, 543–546. doi:10.1016/j.bmcl.2011.10.093

PubMed Abstract | CrossRef Full Text | Google Scholar

Thakur, S., Dhapola, R., Sarma, P., Medhi, B., and Reddy, D. H. (2023). Neuroinflammation in Alzheimer's disease: current progress in molecular signaling and therapeutics. Inflammation 46, 1–17. doi:10.1007/s10753-022-01721-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Toorang, F., Seyyedsalehi, M. S., Sasanfar, B., Rashidian, H., Hadji, M., Mohebbi, E., et al. (2023). Dietary total antioxidant capacity and head and neck cancer: a large case-control study in Iran. Front. Nutr. 10, 1226446. doi:10.3389/fnut.2023.1226446

PubMed Abstract | CrossRef Full Text | Google Scholar

Tullio, F., Angotti, C., Perrelli, M. G., Penna, C., and Pagliaro, P. (2013). Redox balance and cardioprotection. Basic Res. Cardiol. 108, 392. doi:10.1007/s00395-013-0392-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Tung, W. C., Rizzo, B., Dabbagh, Y., Saraswat, S., Romanczyk, M., Codorniu-Hernández, E., et al. (2020). Polyphenols bind to low density lipoprotein at biologically relevant concentrations that are protective for heart disease. Arch. Biochem. Biophys. 694, 108589. doi:10.1016/j.abb.2020.108589

PubMed Abstract | CrossRef Full Text | Google Scholar

Turkyilmaz, I. B., Bilgin Sokmen, B., and Yanardag, R. (2020). Alpha-lipoic acid prevents brain injury in rats administered with valproic acid. J. Biochem. Mol. Toxicol. 34, e22580. doi:10.1002/jbt.22580

PubMed Abstract | CrossRef Full Text | Google Scholar

Turrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335–344. doi:10.1113/jphysiol.2003.049478

PubMed Abstract | CrossRef Full Text | Google Scholar

Tutem, E., Apak, R., and Baykut, F. (1991). “Spectrophotometric determination of trace amounts of copper(I) and reducing agents with neocuproine in the presence of copper(II),”Analyst 116 89–94. doi:10.1039/an9911600089

CrossRef Full Text | Google Scholar

Umezawa, A., Maruyama, C., Endo, Y., Suenaga, Y., Shijo, Y., Kameyama, N., et al. (2022). Effects of dietary education program for the Japan diet on cholesterol efflux capacity: a randomized controlled trial. J. Atheroscler. Thromb. 29, 881–893. doi:10.5551/jat.62832

PubMed Abstract | CrossRef Full Text | Google Scholar

Valkonen, M., and Kuusi, T. (1997). Spectrophotometric assay for total peroxyl radical-trapping antioxidant potential in human serum. J. Lipid Res. 38, 823–833. doi:10.1016/s0022-2275(20)37249-7

PubMed Abstract | CrossRef Full Text | Google Scholar

Vasconcelos, L. H. C., Silva, M., Costa, A. C., DE Oliveira, G. A., DE Souza, I. L. L., Righetti, R. F., et al. (2020). Virgin coconut oil supplementation prevents airway hyperreactivity of Guinea pigs with chronic allergic lung inflammation by antioxidant mechanism. Oxid. Med. Cell Longev. 2020, 5148503. doi:10.1155/2020/5148503

PubMed Abstract | CrossRef Full Text | Google Scholar

Viebahn-Haensler, R., and León Fernández, O. S. (2024). Mitochondrial dysfunction, its oxidative stress-induced pathologies and redox bioregulation through low-dose medical ozone: a systematic review. Molecules 29, 2738. doi:10.3390/molecules29122738

PubMed Abstract | CrossRef Full Text | Google Scholar

Vitale, M., Della Pepa, G., Costabile, G., Bozzetto, L., Cipriano, P., Signorini, S., et al. (2022). Association between diet quality and index of non-alcoholic steatohepatitis in a large population of people with type 2 diabetes: data from the TOSCA.IT study. Nutrients 14, 5339. doi:10.3390/nu14245339

PubMed Abstract | CrossRef Full Text | Google Scholar

Walasek-Janusz, M., Grzegorczyk, A., Malm, A., Nurzyńska-Wierdak, R., and Zalewski, D. (2024). Chemical composition, and antioxidant and antimicrobial activity of oregano essential oil. Molecules 29, 435. doi:10.3390/molecules29020435

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, B., Li, J., Bao, M., Chen, R., Li, H., Lu, B., et al. (2021). Melatonin attenuates diabetic myocardial microvascular injury through activating the AMPK/SIRT1 signaling pathway. Oxid. Med. Cell Longev. 2021, 8882130. doi:10.1155/2021/8882130

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, C., Liu, W., Wei, Y., Guo, X., Zhang, J., Tang, C., et al. (2023). Chemical components of volatile oil extracted from the fermentation broth of ganoderma lingzhi (agaricomycetes) coupled with its antitumor and antioxidant activities in vitro. Int. J. Med. Mushrooms 25, 65–73. doi:10.1615/IntJMedMushrooms.2023047587

PubMed Abstract | CrossRef Full Text | Google Scholar

Winston, G. W., Regoli, F., Dugas, A. J., Fong, J. H., and Blanchard, K. A. (1998). A rapid gas chromatographic assay for determining Oxyradical scavenging capacity of antioxidants and biological fluids. Free Radic. Biol. Med. 24, 480–493. doi:10.1016/s0891-5849(97)00277-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Wong, W. (2020). Economic burden of Alzheimer disease and managed care considerations. Am. J. Manag. Care 26, S177–S183. doi:10.37765/ajmc.2020.88482

PubMed Abstract | CrossRef Full Text | Google Scholar

Wronka, M., Krzemińska, J., Młynarska, E., Rysz, J., and Franczyk, B. (2022). The influence of lifestyle and treatment on oxidative stress and inflammation in diabetes. Int. J. Mol. Sci. 23, 15743. doi:10.3390/ijms232415743

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu, L., Zhou, B., Oshiro-Rapley, N., Li, M., Paulo, J. A., Webster, C. M., et al. (2016). An ancient, unified mechanism for metformin growth inhibition in C. elegans and cancer. Cell 167, 1705–1718.e13. doi:10.1016/j.cell.2016.11.055

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu, M. F., XI, Q. H., Sheng, Y., Wang, Y. M., Wang, W. Y., Chi, C. F., et al. (2023). Antioxidant peptides from monkfish swim bladders: ameliorating NAFLD in vitro by suppressing lipid accumulation and oxidative stress via regulating AMPK/Nrf2 pathway. Mar. Drugs 21, 360. doi:10.3390/md21060360

PubMed Abstract | CrossRef Full Text | Google Scholar

Wu, N., Lu, C., Wang, Y., Liu, L., Lu, D., Zhou, Y., et al. (2023). Semiconducting polymer nanoparticles-manganese based chemiluminescent platform for determining total antioxidant capacity in diabetic mice. Anal. Chem. 95, 6603–6611. doi:10.1021/acs.analchem.2c05624

PubMed Abstract | CrossRef Full Text | Google Scholar

Xie, H., Yang, X., Cao, Y., Long, X., Shang, H., and Jia, Z. (2022). Role of lipoic acid in multiple sclerosis. CNS Neurosci. Ther. 28, 319–331. doi:10.1111/cns.13793

PubMed Abstract | CrossRef Full Text | Google Scholar

Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., et al. (2021). Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol. Rev. 73, 924–967. doi:10.1124/pharmrev.120.000096

PubMed Abstract | CrossRef Full Text | Google Scholar

Yamauchi, M., Kitamura, Y., Nagano, H., Kawatsu, J., and Gotoh, H. (2024). DPPH measurements and structure-activity relationship studies on the antioxidant capacity of phenols. Antioxidants (Basel) 13, 309. doi:10.3390/antiox13030309

PubMed Abstract | CrossRef Full Text | Google Scholar

Yang, C. C., and Chang, K. W. (2018). Eicosanoids and HB-EGF/EGFR in cancer. Cancer Metastasis Rev. 37, 385–395. doi:10.1007/s10555-018-9746-9

PubMed Abstract | CrossRef Full Text | Google Scholar

Yewale, C., Baradia, D., Vhora, I., Patil, S., and Misra, A. (2013). Epidermal growth factor receptor targeting in cancer: a review of trends and strategies. Biomaterials 34, 8690–8707. doi:10.1016/j.biomaterials.2013.07.100

PubMed Abstract | CrossRef Full Text | Google Scholar

Zaak, H., Bendif, H., Rebbas, K., Aouati, L., Abdennour, A., Hamza, A., et al. (2022). Essential oil composition and biological activities of Ononis alba Poir (Fabaceae). Nat. Prod. Res. 36, 2418–2423. doi:10.1080/14786419.2020.1836626

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, C., Yu, H., Shen, Y., Ni, X., Shen, S., and Das, U. N. (2015). Polyunsaturated fatty acids trigger apoptosis of colon cancer cells through a mitochondrial pathway. Arch. Med. Sci. 11, 1081–1094. doi:10.5114/aoms.2015.54865

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, K., Chen, Y., Zhang, T., Huang, L., Wang, Y., Yin, T., et al. (2018). A novel role of Id1 in regulating oscillatory shear stress-mediated lipid uptake in endothelial cells. Ann. Biomed. Eng. 46, 849–863. doi:10.1007/s10439-018-2000-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, P., Li, T., Wu, X., Nice, E. C., Huang, C., and Zhang, Y. (2020). Oxidative stress and diabetes: antioxidative strategies. Front. Med. 14, 583–600. doi:10.1007/s11684-019-0729-1

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, R. X., Liu, F. F., Lip, H., Liu, J., Zhang, Q., and Wu, X. Y. (2022). Pharmaceutical nanoformulation strategies to spatiotemporally manipulate oxidative stress for improving cancer therapies - exemplified by polyunsaturated fatty acids and other ROS-modulating agents. Drug Deliv. Transl. Res. 12, 2303–2334. doi:10.1007/s13346-021-01104-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, A., Liu, K., Liang, X., Li, H., Fu, X., Zhu, N., et al. (2023). Metal-phenolic capsules with ROS scavenging reshape the oxidative microenvironment of atherosclerosis. Nanomedicine 53, 102700. doi:10.1016/j.nano.2023.102700

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhuang, Y., Guo, Z., Zhang, Q., Liu, J., Fei, P., and Huang, B. (2022). Preparation of functionalized pectin through acylation with alkyl gallates: experiments coupled with density functional theory. Int. J. Biol. Macromol. 202, 278–285. doi:10.1016/j.ijbiomac.2022.01.070

PubMed Abstract | CrossRef Full Text | Google Scholar

Zuo, S., Wang, G., Han, Q., Xiao, H., H, O. S., Avelar Rodriguez, D., et al. (2020). The effects of tocotrienol supplementation on lipid profile: a meta-analysis of randomized controlled trials. Complement. Ther. Med. 52, 102450. doi:10.1016/j.ctim.2020.102450

PubMed Abstract | CrossRef Full Text | Google Scholar

Glossary

AAPH 2,2'-Azobis(2-amidinopropane) dihydrochloride

AD Alzheimer’s Disease

ALA Alpha-Lipoic Acid

AMPK/SIRT1 AMP-activated protein kinase/Sirtuin 1

AUC Area Under the Curve

BChE Butyrylcholinesterase

CAT Catalase

CGA Chlorogenic acid

CoQ10 Coenzyme Q10

COPD Chronic Obstructive Pulmonary Disease

CVD Cardiovascular Disease

CUPRAC cupric reducing antioxidant capacity

DPPH 2,2-diphenyl-1-picrylhydrazyl

EGCG Epigallocatechin gallate (corrected from ECG)

EGFR Epidermal Growth Factor Receptor

EOs Essential Oils

ETC Electron Transport Chain

FRAP ferric reducing antioxidant power

GLUT4 Glucose transporter 4

GSH-Px Glutathione peroxidase

H2O2 Hydrogen peroxide

HDL High-Density Lipoprotein

HNC Head and Neck Cancer

HS-GC Headspace Gas Chromatography

KMBA α-Keto-γ-methylthiobutyric acid

LDL Low-Density Lipoprotein

MnSOD Manganese-dependent Superoxide Dismutase

MS Multiple Sclerosis

MT Melatonin

NF-κB Nuclear factor kappa B

NO Nitric oxide

NOX NADPH oxidase

O2 Superoxide anion

ONOO Peroxynitrite

ORAC oxygen radical absorbance capacity

OS oxidative stress

PCOS Polycystic Ovary Syndrome

PCL Photochemiluminescence

PDX-1 Pancreaticoduodenal homeobox factor 1

Prx Peroxiredoxin

ROS Reactive Oxygen Species

RTT Rett Syndrome

SOD Superoxide dismutase

TEAC Trolox-Equivalent Antioxidant Capacity

TOSC total oxidant scavenging capacity

TRAP total radical-trapping antioxidant Parameter

Trx Thioredoxin

T2D Type 2 Diabetes Mellitus

VEGF Vascular Endothelial Growth Factor

VPA Valproic acid

OH hydroxyl radical

Keywords: oxidative stress, molecular mechanism, detection methods, antioxidants, diseases

Citation: Gao Q, Jiang L, Sun Y, An X, Sun W, Tang S, Kang X, Zhao X, Li Z, Liu C, Ji H and Lian F (2025) Oxidative stress: from molecular studies to clinical intervention strategies. Front. Mol. Biosci. 12:1638042. doi: 10.3389/fmolb.2025.1638042

Received: 02 June 2025; Accepted: 11 August 2025;
Published: 04 September 2025.

Edited by:

Lidija Milkovic, Rudjer Boskovic Institute, Croatia

Reviewed by:

Sathish Sivaprakasam, Texas Tech University Health Sciences Center, United States
José Díaz-Chávez, Instituto Nacional de Cancerología (INCAN), Mexico

Copyright © 2025 Gao, Jiang, Sun, An, Sun, Tang, Kang, Zhao, Li, Liu, Ji and Lian. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Hangyu Ji, amloYW5neXVlY2hvQDE2My5jb20=; Fengmei Lian, bGZtNTY1QHNvaHUuY29t

These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.